nutrients Review Feeding the Brain: Effect of Nutrients on Cognition, Synaptic Function, and AMPA Receptors Rut Fadó 1,2,3, * , Anna Molins 1 , Rocío Rojas 1 and Núria Casals 1,2 1 Basic Sciences Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, E-08195 Sant Cugat del Vallès, Spain 2 Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, E-28029 Madrid, Spain 3 Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, E-08193 Cerdanyola del Vallès, Spain * Correspondence: rfado@uic.es; Tel.: +34-93-504-20-00 Abstract: In recent decades, traditional eating habits have been replaced by a more globalized diet, rich in saturated fatty acids and simple sugars. Extensive evidence shows that these dietary factors contribute to cognitive health impairment as well as increase the incidence of metabolic diseases such as obesity and diabetes. However, how these nutrients modulate synaptic function and neu- roplasticity is poorly understood. We review the Western, ketogenic, and paleolithic diets for their effects on cognition and correlations with synaptic changes, focusing mainly (but not exclusively) on animal model studies aimed at tracing molecular alterations that may contribute to impaired human cognition. We observe that memory and learning deficits mediated by high-fat/high-sugar diets, even over short exposure times, are associated with reduced arborization, widened synaptic cleft, narrowed post-synaptic zone, and decreased activity-dependent synaptic plasticity in the hippocam- Citation: Fadó, R.; Molins, A.; Rojas, pus, and also observe that these alterations correlate with deregulation of the AMPA-type glutamate R.; Casals, N. Feeding the Brain: ionotropic receptors (AMPARs) that are crucial to neuroplasticity. Furthermore, we explored which Effect of Nutrients on Cognition, diet-mediated mechanisms modulate synaptic AMPARs and whether certain supplements or nutri- Synaptic Function, and AMPA tional interventions could reverse deleterious effects, contributing to improved learning and memory Receptors. Nutrients 2022, 14, 4137. in older people and patients with Alzheimer’s disease. https://doi.org/10.3390/ nu14194137 Keywords: diet; cognition; memory; learning; hippocampus; synaptic function; neuroplasticity; Academic Editors: Luisa Cigliano, BDNF; AMPARs; neurodegeneration Maria Stefania Spagnuolo and Arianna Mazzoli Received: 13 September 2022 1. Introduction Accepted: 30 September 2022 Published: 5 October 2022 The growing prevalence of cognitive impairment and dementia, with 100 million cases estimated by 2050, is becoming a serious public health concern with both individual Publisher’s Note: MDPI stays neutral and socioeconomic burdens [1]. Although the rise in life expectancy is one of the main with regard to jurisdictional claims in causes of the increased prevalence, multiple other factors are likely to play a role. In recent published maps and institutional affil- years, increasing attention has been paid to the impact of diet on brain health and mental iations. function [2,3], with several dietary components, such as carbohydrates, fats, and hormones, reported to influence cognition [1]. Indeed, the consumption frequency of healthy or unhealthy foods perfectly correlates with better or worse cognitive performance in older Copyright: © 2022 by the authors. adults [4]. It would seem, therefore, that our diet directly affects brain health and the Licensee MDPI, Basel, Switzerland. probability of developing dementia and neurodegenerative disorders in later life. This article is an open access article The consumption of high-fat/high-sugar diets in modern civilizations, combined distributed under the terms and with overeating behaviors and sedentary lifestyles, has led to exponential growth in obe- conditions of the Creative Commons sity cases worldwide, reported to be 650 million people in 2016, according to the World Attribution (CC BY) license (https:// Health Organization (WHO) [5]. Obesity increases the risk of developing dementia in later creativecommons.org/licenses/by/ life [6,7], and has been associated with immediately altered cognitive performance, includ- 4.0/). ing impaired verbal learning, working memory, stimulus reward learning, and executive Nutrients 2022, 14, 4137. https://doi.org/10.3390/nu14194137 https://www.mdpi.com/journal/nutrients Nutrients 2022, 14, 4137 2 of 36 functions (adaptation to novel situations, cognitive flexibility, attention span, planning, and judgment) [8–10]. Obesity is also considered a risk factor for developing multiple comor- bidities, such as type 2 diabetes (T2D), hypercholesterolemia, hypertension, and metabolic syndrome (MetS), all of which may have an independent impact on cognition. In fact, T2D (with 422 million cases in 2014, according to the WHO, [11]) correlates with cognitive dysfunction, including reduced information processing speed and altered verbal, visual memory, and executive functions [12–14]. Even impaired glucose tolerance, which develops prior to T2D, is considered a risk factor for cognitive damage [15]. In addition, also associ- ated with a higher risk of cognitive impairment and dementia is MetS [16–18], defined as a multifactorial disorder characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia [19]. However, still poorly understood are the physiopathological mechanisms by which metabolic diseases affect learning and memory processes, and raise the risk of late-life dementia and neurodegeneration. During learning and memory task performance, neural networks, in a process called neuroplasticity [20], make new connections and/or adjustments in synaptic strength, es- pecially in the hippocampal glutamatergic circuits. This reorganization is carried out by tight control of the number of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate ionotropic receptors (AMPARs) in the post-synaptic zone (PSZ). Since glutamate is the major excitatory neurotransmitter in the central nervous system, AMPARs are the main mediators of fast synaptic transmission. Functional receptors are tetrameric assemblies of subunits GluA1-4. Whereas GluA4 is mostly expressed during early development stages, in mature excitatory neurons, AMPARs contain two dimers of GluA1/GluA2 (~80% of all synaptic AMPARs) or GluA2/GluA3 heteromers [21]. In resting conditions, the presence of GluA2 in surface AMPARs makes these Ca2+ -impermeable [20]. Following stimulation with glutamate, precise regulation leads to synaptic incorpora- tion of GluA1-GluA1 homomers. These GluA2-lacking AMPARs are Ca2+ -permeable (CP-AMPARs), and, over a restricted period of time, induce Ca2+ -sensitive signaling events that sustain synaptic potentiation or modulate subsequent neuroplasticity. However, aber- rant incorporation of CP-AMPARs can result in excessive Ca2+ influx, inducing excitotoxic- ity and cell death, as reported for brain diseases [22]. An excitotoxic influx of Ca2+ is also mediated by overactivation of N-methyl-D-aspartate (NMDA)-type glutamate ionotropic receptors (NMDARs) [23]. Functional NMDARs are tetramers of GluN1 (A or B) and GluN2 (A-D), and are also involved in neuroplasticity modulating synaptic incorporation of CP-AMPARs. Changes in the expression of a particular subunit of AMPARs produce an imbalance in AMPAR tetrameric composition or dysregulate its trafficking toward the PSZ, and both have been linked to Alzheimer’s disease (AD) and cognitive aging [21,24]. In AD, high levels of amyloid-β oligomers (Aβ)—a main pathological hallmark, together with Tau phosphorylation—induce readjustments in the synaptic insertion of CP-AMPARs [25,26]. Soluble Aβ oligomers reduced surface expression of AMPARs and blocked their extrasynaptic delivery mediated by chemical synaptic potentiation in neuronal cultures [26]. However, intracellular infusion of oligomeric Aβ enhanced AMPAR-mediated synaptic transmission in hippocampal slices, but the knockdown of GluA1 prevented this effect, suggesting that intracellular Aβ induced synaptic insertion of CP-AMPARs [25]. In any case, Aβ dysregulates AMPAR trafficking [27] and AMPAR-mediated synaptic plasticity impairment is one of the early onsets of AD (reviewed by [21]). This early synaptic dysfunction largely precedes any sign of cognitive decline, in both neurodegenerated and aged brains [21,28]. The fact that im- paired learning and memory processes in AD and aged people are exacerbated by unhealthy diets [29], underlines the impact of nutritional factors at the synaptic level. Additionally, dynamic regulation of AMPARs has been associated with different metabolic situations, orexigenic and anorexigenic hormones (like leptin and ghrelin), and dietary factors [30–34]. In summary, it is becoming evident that dietary habits and specific nutrients play an essential role in brain health. However, solid evidence of nutritional control of synap- Nutrients 2022, 14, 4137 3 of 36 tic function focused on AMPARs and its correlation with cognitive performance is not completely understood. Therefore, our main aim in this narrative review was to comprehensively compile, from the literature, analyses of the effects of the main dietary habits and nutritional factors on cognition, synaptic function, and AMPAR dynamics. In particular, in an endeavor to clarify conflicting findings, we review the effects on learning and memory processes of diets with high sugar, fat, and/or protein content (such as the Western, ketogenic, and paleolithic diets), focusing especially on nutrient composition, exposure time, and differences between sexes and age groups. Focusing especially on readjustments in synaptic AMPARs, we also document existing evidence on the association between early dysfunction in hippocampal synapses and cognitive impairment, summarizing the pathways that may explain nutrient- mediated modulation of neuroplasticity. Disentangling the molecular mechanisms that underpin the damaging or neuroprotective effects of certain nutrients may help design better dietary interventions and therapeutic approaches, both to the prevention of cognitive decline linked to aging and to neurodegenerative and metabolic diseases. 2. Western Diet In recent decades, most societies have gradually abandoned dietary traditions to globalize their lifestyles. In southern Europe, for instance, the Western diet (WD), featured by high animal-based food, fat, and simple sugar intake, is gradually replacing the primarily plant-based Mediterranean diet (MedDiet), rich in vegetables, fruit, whole grains, olive oil, and fish, and low in red meats and refined sugars [35], and associated with a lower rate of cognitive function decline [36]. It has been documented that diets high in either fats or simple sugars have dele- terious effects on cognition (discussed below), so the combination of both in the WD evidently contributes to memory and learning impairments. In lean young humans, a 4- or 8-day intervention with a Western style-based breakfast (high in saturated fats and added sugars) was enough to reduce hippocampal-dependent learning and memory [37,38]. In a longitudinal study of elderly people, the WD was a predictor of poorer memory and processing speed [39]. There is, however, little literature analyzing the effects of the WD and its components on brain function in humans [40], which is why we revisit experimental approaches with animal models. 2.1. Cognition Studies in Animal Models While several high-fat diet (HFD)/high-sugar diet (HSD) protocols in animal models aim to mimic the WD in humans, many factors determine cognitive outcomes, such as the nature and percentages of fats and sugars (in WD-mimetics approaches, and in healthier control diets typically composed of 45–65% carbohydrates and 5–15% fats), palatability, exposure over time, individual susceptibility or resistance to obesity, and cognition tests used to measure learning and memory. With just a few exceptions, in which no differences were reported at 5, 10, or 12 weeks of the WD [41–43], a wide range of experimental models have demonstrated negative WD effects on learning and on short- and long-term memory, the details of which are summarized in Table 1. As happens in humans, short exposition to Western style-based breakfast was enough to reduce memory in rodents. Five days of exposure to a non-standardized cafeteria diet (CAFD) composed of cakes, biscuits, and a protein source, plus a high-sucrose (HSu) solution, compromised hippocampal-dependent place recognition memory in adult rats, although other memory tasks remained unaffected [49]; comparable deficits were also reported for the CAFD without the HSu solution and the HSu solution without the CAFD. In young rat females, 5 weeks of CAFD or high-fructose solution (HFru) intake induced similar memory impairments, and intervention with a healthier diet was only able to revert HFru-mediated, but not CAFD-mediated deficits [44]. In adult mouse males, 14 weeks of combined HFD and HFru (HFD-HFru) intake resulted in a poorer cognitive performance than with an HFD alone [69]. To the best of our knowledge, there are no studies proving Nutrients 2022, 14, 4137 4 of 36 whether longer-term consumption of an HFD or HSD have additive effects in memory loss and synaptic function. However, we believe that this is likely the case, since high intake of both would simultaneously damage different signaling pathways with the same result. Table 1. WD effects on synaptic function and cognition in animals. Species, Sex, Age Synaptic Function, Exp. Approach Model Learning/Memory Neuroplasticity Other Pathways Refs. Short periods (≤2 months) CAFD (F/sucrose: 45%) & HFru Impaired memory solution (11%) or (novel object in HFru solution context) at 5 w for Gut dysbiosis Young animals Rat (♀; 3 w) alone vs. CD (F: CAFD and HFru - (before and after [44] 13.4% & C: 56.7%) solution. No reversion) for 5 w. reversion in Reversion: 5 w CAFD group with CD HFD-HDextrose (F: 41.7% & C: Impaired memory ↓ dendritic arborization in Rat (♂; 6 w) 36.7%) vs. CD (F: (NOR; no changes HPC neurons and ↑ in ↑ TNFα levels in [45] 13.5% & C: 58%) entorhinal cortex neurons blood with MWM) for 11 w CAFD (cakes, biscuits & a protein source) & Impaired memory No changes in BDNF, TrkB ↑ inflammation Rat (♂; 6 w) and gut dysbiosis [46] HSu solution (NOR and NLR) and synapsin in HPC (10%) vs. CD for 6w HFD (F:39%) & refined sugar Impaired memory ↓ BDNF, phosphosynapsin I Rat (♀; 2 m) (40%) vs. CD (F: - [47] 13% & complex C: (MWM) and phosphoCREB 59%) for 2 m Impaired HFD (F: 60% & C: hippocampal- Rat (♂and ♀; 20%) HFru dependent Adult animals solution (11%) vs. - - [48] 9–10 w) CD (F: 13% & C: memory (NLR) in 62%) for 6 w ♂(no changes in ♀) CAFD (F: 45% & Impaired C: 50%) & HSu hippocampal- Rat (♂; adult) solution (10%) vs. dependent No changes in BDNF ↑ inflammation in [49] CD (F: 15%, & C: HPC at 20 d 59%) for 5, 11 & memory (NLR; no 20 days changes in NOR) CAFD (CD supplemented with cakes, Impaired memory Rat (♂) biscuits & protein - Gut dysbiosis [50] (NLR) source) & HSu solution (10%) vs. CD for 5 w HFD-HC (F: 25%, Impaired C: 44% & P: 18%) short-term and ↑ oxidative stress Rat (♂; adult) vs. CD (F: 5%, C: long-term No changes in BDNF in HPC [51] 62% & P: 18) for 6w memory (RAWM) HFD (F: 40%, P: 5% & C: 15%) & HSu solution (40%) vs. CD (F: Impaired memory 15%, P: 25% & C: (NLR). Reversed - - Rat (♂) 55%) for 6 w. [52] by CD and Reversion: 3 w training with HFD-HSu and 3 w with CD and training Nutrients 2022, 14, 4137 5 of 36 Table 1. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Model Learning/Memory Neuroplasticity Other Pathways Refs. HFD (SFAs & Altered levels in MUFAs; 38%) & energy refined sugar Impaired memory ↓ GluA3 levels in dorsal Rat (♂) HPC and altered levels in metabolism [53] (38%) vs. CD (F: (NOR) and markers (by 6% & sugar: 4.1%) learning (MWM) synaptic plasticity markers proteomic for 8 w analysis) Long periods (>2 months) HFD (F: 29%, sucrose: 34% & cholesterol 1.25%) Gut dysbiosis, ↑ & ↓ PSD95 and BDNF, ↓ LTP Young animals Rat (♂; 21 days) HGlucose-HFru - inflammation and [54] solution in HPC microglia (55%/45%) vs. activation in HPC CD (F: 6% & C: 44%) for 8 m HFD (30% lard & 66% sucrose) & HSu solution Impaired memory No changes in Rat (♀; 1 m) ↓ TrKB, ↓ LTP in HPC [55] (30%) vs. CD (F: (NOR) neurogenesis 3%, C: 61% & P: 19%) for 24 m HFD & HSu Impaired spatial solution (5%) vs. and working Gut dysbiosis. CD for 4 m. memory (T-maze - Rat (♂; 5–7 w) Reversion: 3 m Reversed by [56] and NOR). bioactive foods with bioactive Reversed by food bioactive foods ↑ BBB HFD-HFru (F: permeability, neu- 30% & fructose: Impaired learning Rat (♂; 6 w) - rodegeneration [57] 15%) vs. CD for (MWM) 6m and microglia activation HFD-HFru (saturated F: 45% Impaired memory ↓ IGF1 and ↑ Rat (♂; 6 w) - [58] & fructose: 20%) (NOR) oxidative stress vs. CD for 11 w HFD-HSu (F: 60% ↓ GluA1, BDNF, & sucrose: 7%) vs. Impaired memory phosphoCREB, TrkB in HPC Mouse (♂; 6 w) CD (F: 17%) for ↓ neurogenesis [59] (NOR) and PFC 13 w HFD (F: 40% & C: ↓ GLUT1/3, ↑ ER 20%) & HSu ↓ PSD95 and ↑ phosphoTau stress and Mouse (♂; 7 w) solution vs. CD - in brain (no changes in inflammation [60] (F: 12% & C: 67%) responses and synaptophysin) INS resistance in for 14 w brain CAFD (CD with cookies, cakes & biscuits) vs. CD ↑ BDNF and TrkB and ↓ Rat (♂; 7 w) once per day, - phosphoTrkB in PFC. No Redox imbalance [61] 5 days per week changes in HPC for 5 m HFD (F: 40%, C: 45% & P 15%) & Impaired memory ↑ oxidative stress HFru solution (MWM) at 16 and and reduced Rat (♀; 8–10 w) (15%) vs. CD (F: 24 w (no changes - antioxidant levels [43] 6%, C: 64% & P: in HPC and CTX 25%) for 12, 16 & at 12 w) 24 w Impaired learning HFD-HGlucose (nonspatial ↑ BBB Rat (♂; 2 m) (F: 40%) vs. CD - permeability in [62] (F: 13%) for 3 m discrimination HPC learning problem) HFD (SFAs & MUFAs: 39%) & Impaired learning refined sugar and memory ↓ BDNF and synapsin I in Rat (♀; 2 m) HPC - [63] (40%) vs. CD (F: (MWM) at 1 and 13% & C: 59%) for 2m 1, 2 & 6 m or 2 y Nutrients 2022, 14, 4137 6 of 36 Table 1. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Model Learning/Memory Neuroplasticity Other Pathways Refs. HFD (high-lard or No changes in ↓ GluN2A in high-lard-HSu Rat (♂; 2 m) high-olive oil) & spatial memory (no changes in high-olive - [42] HSu solution vs. (Y-maze) oil-HSu) in CTX CD for 10 w HFD-HSu & HFru corn syrup Impaired learning ↓ dendritic spine density, ↓ Rat (♂; 2 m) LTP and ↓ BDNF levels in - [64] solution (20%) vs. (MWM) CD for 8 m CA1-HPC Impaired memory HFD (F: 60%) & (NOR and NLR. ↑ microglia HSu solution No change in activation (no Mouse (♀and ♂; (20%) vs. CD (F: inflammation and 10 w) 10%) for 4 or 6 m. working memory [65] neuronal loss). Reversion: 8 w (Y-maze). Recovered after 8 with CD Recovered after 8 w of CD w of CD HFD-HSu (F: 20% Guinea pigs & sucrose: 15%) vs. CD (F: 4% & - ↓ BDNF levels in HPC - [66] (♀; 10 w) sucrose: 0%) for 7m HFD-HDextrose Rat (♂; (SFAs: 41.7%) vs. Impaired memory CD (F: 13.4%) for - - [67] adolescent) (NOR) 10 w INS resistance, ↑ HFD (F: 45%) & microglia HFru solution Impaired memory ↓ PSD95 and SNAP25 in Adult animals Mouse (♂; 3 m) (10%) vs. CD for HPC activation and [68] (MWM) inflammation in 10 w brain HFD-HDextrose (F: 38%, P: 24%, C: Impaired learning ↑ BBB 18% & dextrose: permeability in Rat (♂) 20%) vs. CD (F: at 10 and 90 d, no - [41] 18%, P: 24%, C: changes at 40 d HPC (only in 58%) for 10, 40 & (Y-shaped maze) obese rats) 90 days HFD-HFru (F: Impaired memory 48%, fructose: ↓ glutamate and glutamine 33% & P: 19%) or (NOR and NLR). Mouse (♂; 3 m) HF-HFru more in HPC (no changes in - [69] HFD (F: 48%, C: 33% & P: 19%) vs. affected than GABA) CD for 14 w HFD HFD-HDextrose (F: 40%, P: 21% & Impaired learning C: 38%) or (nonspatial ↓ BDNF in prefrontal CTX HFD-HSu (F: Pavlovian and HPC with - Rat (♂) 40%, P: 21% & C: HF-HDextrose (no changes [70] discrimination 38%) vs. CD (F: and reversal with HF-HSu) 12%, P: 28% & C: learning problem) 59%) for 3 m HFD-HFru (CD: Impaired learning 60%, fructose: (MWM and Rat (♂and ♀) 30% & pork fat: passive avoidance - ↑ oxidative stress [71] 10%) vs. CD for test). ♂more 12 w affected than ♀ Short vs. long periods HFD-HFru (30% lard, 0.5% cholesterol and Impaired learning 15% fructose, all (MWM) at 14 w ↑ BBB Young animals Mouse (♂; 6 w) in - permeability and [72] (no changes at astrocytocis weight/weight) 4 w) vs. CD for 4 or 24 w WD effects in animals were classified according to experimental approach, taking into account exposure time, short (≤2 months) or long (>2 months) periods, sex, and age classified as young and adult (≤2 months, >2 months). Search terms used were as follows: “western diet” OR “high fat” AND “sugar”, “sucrose”, “fructose” OR “dextrose” AND “memory”, “learning”, “synaptic plasticity” OR “AMPAR”. Only studies with rodents were Nutrients 2022, 14, 4137 7 of 36 included. Excluded were experimental models of maternal exposure, streptozotocin-treated animals, and pathological conditions. Percentage fats, carbohydrates, and proteins are relative to total energy unless otherwise indicated. Solution percentages are expressed as weight/volume unless otherwise indicated. Table symbols and abbreviations are as follows: ♀: female; ♂: male; ↑: increased; ↓: decreased; BBB: blood-brain barrier; BDNF: brain-derived neurotrophic factor; C: carbohydrates; CAFD: cafeteria diet; CD: control diet; CREB: cAMP response element- binding protein; CTX: cortex; ER: endoplasmic reticulum; F: fats; FC: fear conditioning; GABA: gamma-aminobutyric acid; GluA: AMPA receptor; GluN: NMDA receptor; GLUT: glucose transporter; h: hours; HC: high carbohydrate; HDextrose: high dextrose; HFD: high-fat diet; HFru: high fructose; HGlucose: high glucose; HPC: hippocampus; HSD: high-sugar diet; HSu: high sucrose; INS: insulin; IGF1: insulin-like growth factor 1; LTD: long-term depres- sion; LTP: long-term potentiation; m: months; MUFAs: monounsaturated fatty acids; MWM: Morris water maze; NLR: novel location recognition; NOR: novel object recognition; P: protein; PFC: prefrontal cortex; phospho: phos- phorylated; PSD95: postsynaptic density protein 95; PUFAs, polyunsaturated fatty acids; RAWM: radial arm water maze; SFAs: saturated fatty acids; SNAP25: synaptosomal-associated protein 25; SOLF: saturated oil-enriched food; TNFα: tumor necrosis factor; TrkB: tropomyosin receptor kinase B; UOLF: unsaturated oil-enriched food; vs.: versus; and w: weeks. Especially relevant is the fact that this brain damage is not equal in both sexes. In adult animals, females seem to be more resistant to WD-induced cognitive impairment than males [48,71]. Males are reported to consume a high percentage of calories from fats and proteins, while females show a greater preference for sweet-related calories [48]. However, sexual dysmorphism in nutrient choice is not the only reason to explain sex- specific consequences of the WD on cognitive outcomes, as sex hormones play an important role. In male rats, gonadectomy reverted HFD-HFru effects on some learning and memory tasks, but did not improve or even worsen the effects in females [71]. In non-human primates on an obesogenic diet, estrogen replacement therapy after an ovo-hysterectomy increased cognitive performance [73]. More in-depth studies analyzing sex- and hormone- dependent effects of an HFD or HSD on synaptic and cognitive injury could lead to better diet interventions for patients with MetS, especially for women after the menopause. There is hope in the fact that WD-induced impairment in memory seems to be re- versible, as demonstrated for male and female young animals switched from 4 months on an HFD/HSD to a more balanced control diet for 6 weeks [52,65], and also for male adult animals on a 3-week WD followed by a 3-week control diet [62]. By contrast, AD- related pathology would be exacerbated by the WD, which has been shown to accelerate age-associated cognitive decline in AD animal models (as demonstrated, for example, in [74,75]). Moreover, the cognitive dysfunction associated to MetS can be countered by life-style strategies in clinical and preclinical studies, including healthy dietary habits, some dietary supplements (like vitamins and antioxidants), reduced calorie intake, and exercise [76,77], whereas no medications successfully treat cognitive impairment in these patients. Neither antihypertensive, statins nor drugs for AD have revealed efficiency on slowing cognitive deficits in preclinical models of MetS [78,79]. By contrast, high adherence to the MedDiet decreased the risk of developing cognitive impairment and dementia even in individuals with established MetS [77,80]. Accordingly, meals with a high content in fruits and vegetables, or in fish, exhibit a significant inverse association with cognitive decline in the general population and have a preventive role in cognition-related alteration associated with MetS [81,82]. In summary, healthy nutritional habits and lifestyle interven- tions are nowadays the best therapeutic strategy to reduce MetS components and prevent or delay cognitive decline. 2.2. Synaptic Function and Neuroplasticity WD-compromised acquisition of new information in learning and memory processes perfectly correlates with deficits in hippocampal dendrites, synapsis morphology, and activity-dependent functional plasticity, as exemplified by the long-term potentiation (LTP) paradigm. LTP is an electrophysiologic high-frequency stimulation protocol that mim- ics physiologic activity during learning and memory [20]. This stimulation increases Nutrients 2022, 14, 4137 8 of 36 the number of CP-AMPARs (GluA1-GluA1 tetramers) in the PSZ, inducing trafficking to the cell surface via the recycling pathway and lateral movement from perisynaptic sites, and enhancing synaptic transmission efficiency. It has been reported that long-term WD-impaired synaptic plasticity in the hippocampus (HPC) reduces dendritic spine density and LTP [54,55,64], and also that the WD alters dendritic arborization, which is reduced in the HPC and increased in the entorhinal cortex [45]. This last finding could be a compen- satory effect due to synaptic loss in distal regions like the HPC or even in proximal synapses, since the WD has also been reported to impair episodic memory in this particular case. WD-mediated cognitive impairment is associated with deficits in certain synap- tic proteins. Levels of the main neurotrophin, i.e., brain-derived neurotrophic factor (BDNF), were reduced in the HPC of adult mice after long-term exposure (2–8 months) to the WD [47,54,63,64,66,70], while no differences were observed for shorter exposure (20–42 days) [46,49,51]. A decrease in the BDNF receptor, tropomyosin receptor kinase B (TrkB), has also been reported [55,59]. Interestingly, not all nutritional sources alter BDNF levels in the same way. While a high-dextrose HFD downregulated BDNF in both the HPC and prefrontal cortex (PFC), this was not the case for a high-sucrose HFD [70]. Moreover, proteomic analysis of the dorsal HPC of rats on the WD for 8 weeks re- vealed alterations in synaptic plasticity markers, including a specific reduction in AMPAR subunit GluA3 [53]. In fact, selectively decreased synaptic GluA3 has also been shown to be involved in dendritic spine loss in frontotemporal dementia [83]. Other long-term WD paradigms demonstrate reductions in other glutamate receptors, including the AMPAR subunit GluA1 (at 13 weeks) [59] and the NMDAR subunit GluN2A (at 10 weeks) [42]. The decrease in GluA1 may occur because BDNF regulates its synthesis [84]. At synaptic sites, GluN2A-lacking NMDARs may display altered synaptic plasticity, as described for its deletion in pyramidal cells from HPC slices [85]. Lower levels of glutamate and its precursor, glutamine, have also been detected in the HPC of HFD-HFru- and HFD-fed mice, while gamma-aminobutyric acid (GABA), the most common inhibitory neurotrans- mitter, remained unaltered [69]. Short-term studies are needed, nonetheless, to understand whether the deleterious effects of the WD on memory loss are a cause or consequence of changes in the glutamate neurotransmitter and its receptors. 2.3. Other Mechanisms Other mechanisms are also compromised in WD-induced cognitive damage: insulin (INS) signaling in the brain [60,68], blood-brain barrier (BBB) permeability [41,57,62], HPC inflammation [45,46,49,54,60,68], microglia activation [54,57,65,68,72], endoplasmic reticulum (ER) and oxidative stress [43,51,58,60,61,71], gut microbiome composition [44,46,54,56,58], and neurogenesis [59]. Therapeutic strategies based on modulating these mechanisms have demonstrated unequal effects on memory loss. Insulin supplementation has been shown to prevent WD-reduced neuroplasticity [54], and treatment with metformin, the first line drug for T2D, improved cognitive function in HFD-HFru-fed mice, but failed to restore BBB permeability [57]. It remains unclear whether the loss of BBB permeability mediated by the WD is a cause of memory loss. It has been reported that an HFD-HFru produced BBB dysfunction after 4 weeks, but no significant decline in learning and memory [72]. In contrast, other studies, using different HFD/HSD paradigms, showed cognitive impairment after shorter exposure to the WD [41,49,63], in one case, reporting increased BBB permeability in WD-induced obese subjects at 12 weeks, but not in WD-resistant obese subjects at 5 weeks [41]; this would suggest that BBB leakage could, depending on exposure time, diet composition, and obesity phenotype, be a consequence of the WD. Furthermore, pre-exposure to a probiotic called VSL#3 prevented WD-induced mem- ory deficits for an HPC-dependent task, but caused deficits for a perirhinal-dependent task, irrespective of diet and dose [50], suggesting that this probiotic may be detrimen- tal for healthy subjects. In one study, treatment with the antibiotic minocycline, which alters microbiome composition, prevented or reverted CAFD-induced spatial memory Nutrients 2022, 14, 4137 9 of 36 impairment [46]; however, another study showed that dietary intervention restored CAFD- dependent memory loss, but not gut microbiota alterations [44]. Finally, vitamin E adminis- tration normalized the effect of the CAFD on HPC oxidative stress markers and prevented diet-mediated memory decline [51]. The above are just some examples of efforts focused on discovering new drugs and/or bioactive foods with neuroprotective properties that could counteract HFD/HSD-induced brain damage. In conclusion, an association between WD and alterations in memory and learning processes has been demonstrated both in human studies and experimental approaches on animal models. Such effects correlated with synaptic and neuroplasticity dysfunctions in the hippocampus, corresponding with reduced dendritic spine density and arboriza- tion, decreased LTP, and deficits in synaptic proteins, like AMPARs. Furthermore, other mechanisms regarding INS signaling and BBB permeability, among others, appeared to be affected too. Fortunately, WD-induced cognitive decline seems to be reversible, as shown in animal studies that switched from an HFD/HSD to a more balanced control diet. However, more in-depth investigations are required to fully understand the effect of WD and its components on brain function to create better diet interventions to ameliorate cognitive alterations. Interestingly, more knowledge about the effects of nutrients at cognitive, synaptic and neuroplasticity level can be achieved reviewing current evidence with HFD alone (especially considering the fat type) and HSD alone (comparing fructose and sucrose intake), as documented in the following chapters. 3. High-Fat Diet In humans, combined high-fat/high-sugar intake (as in the WD) is more frequent than an HFD alone (35–60% calories from fats), yet it is difficult to obtain a real picture of HFD impact on cognition, due mainly to variations between studies in terms of methodology, study type, target population, self-reported diet intake, measured neuropsychological tasks, and the limited number of articles included in quantitative analyses. 3.1. Cognition Studies with Mixed and Saturated Fats While it has been widely reported that the WD impairs memory in the general pop- ulation, an HFD alone failed to reach statistical significance in the latest systematic re- view [40]. Although cognitive performance is affected differently by the fat type (animal- or plant-based), not all the studies specified type, making it more difficult to draw reliable conclusions. Although excessive fat intake can have detrimental effects on cognition at any age, certain life stages seem to be especially sensitive, namely, the adolescent and elderly stages; higher habitual intake of unhealthy saturated fats (solid fats that come mainly from animals, such as meat and dairy) and trans fats (liquid oils that become solid in processed foods) was more clearly associated with impaired memory performance in young and older age groups than in healthy adult groups [86–90]. Moreover, contributing more to cognitive decline than excessive calorie intake is exposure to certain types of obesogenic dietary com- ponents, like saturated and trans fatty acids [91]. More controlled experimental approaches with HFD-fed animals models would throw light on the precise effect of fats on synaptic function, as well as the cellular and molecular mechanisms involved in cognitive decline. As indicated by the animal studies summarized in Table 2, both young and aged animals are, like humans, susceptible to HFD-induced brain damage. Although the nature of the fats used is not always reported, in most cases, an HFD typically consists of a mix of fats, with a predominance of saturated fats over unsaturated fats. Apparently, 3-days consumption of a mixed HFD by aged animals was enough to damage HPC-dependent long-term but not short-term memory, while younger adults remained unaffected [92]; however, another study has demonstrated that short-term memory was also impaired after 7 days on a mixed HFD [93]. In neurodegeneration linked to AD, a mixed HFD induced long-term memory impairment, but no changes in short-term memory [94]. Moreover, early life exposure to a mixed HFD produced learning and memory deficiencies in aging Nutrients 2022, 14, 4137 10 of 36 females, even if a healthier diet was consumed during adulthood [95]. Thus, both early and late life stages are particularly vulnerable to obesogenic diets, which initially affect long-term, then short-term memory. However, it is important to note that a long-term mixed HFD impaired cognition even in adulthood [96–99]. Furthermore, foods enriched with saturated fat, trans fat, and/or cholesterol, even over short periods, had deleterious effects on the memory of young, adult, and aged animals when compared with iso-caloric control diets [100–103]. Table 2. Mixed or saturated HFD effects on synaptic function and cognition in animals. Species, Sex, Age Synaptic Function, Exp. Approach Model Learning/Memory Neuroplasticity Other Pathways Refs. Days (≤2 weeks) Impaired long-term memory (NLR) in Saturated HFD (F: young animals ↑ glucocorticoids Rat (♂; 3 w 60% & C: 20%) vs. ↓ LTP in CA1-HPC in young Young animals & 2 m) CD (C: 35%) for but improved in release in young [103] animals, but ↑ in old ones 7 days old ones. No animals changes in short-term memory HFD (F: 45% & C: Mouse (♂; 5 w) 35%) vs. CD (F: - ↓ LTP in HPC. No changes - [104] 18% & C: 58%) for in LTD 2 days ↑ BBB permeability at 1–3 days (no HFD (F: 60% & C: changes 27%) vs. CD (F: Impaired memory ↓ synaptophysin at 7 days in Mouse (♂; 6 w) 10% & C: 70%) for at 4–6 days) and [105] (NOR) at 3–7 days HPC. No changes at 3 days 1 to 7 days inflammation at 2 days (no changes at 1 or 3–7 days) HFD (F: 60% & C: Mouse (♂; 6 w) 21%) vs. CD (F: - ↓ BDNF and dendritic tree - [106] 13% & C: 67%) for in HPC 7 days Saturated HFD (F: Impaired memory 48% & C: 37%) or Gut dysbiosis. No PUFA HFD (F: (NLR) with No changes in BDNF in changes in Adult animals Rat (♂) 46% & C: 37%) vs. saturated. No HPC [100] changes with inflammation in CD (F: 21% & C: HPC 56%) for 2 w PUFA HFD (F: 30% by Impaired memory ↓ PSD95, BDNF, thickened Gut dysbiosis, ↑ weight) vs. CD (F: (NOR, Y-maze & of post synaptic density, & ↑ microglia Mouse (♂; 10 w) temporal order activation, & [93] 5% by weight) for width of synaptic cleft in inflammation in 7 days memory test) HPC & PFC HPC & PFC Alterations in Saturated HFD (F: metabolism, cell 60%) vs. CD (F: stress, Mouse (♂; 12 w) 10%) in animals - - inflammation, cell [107] for 3 days, 1 or signaling & 2w cytoskeleton Impaired long-term memory (FC & ↑ microglia Mixed HFD (F: MWM) in aged activation & Young vs. aged Rat (♂; 3 m & 60.3% & C: 21.3%) inflammation in animals. No - [92] animals 24 m) vs. CD (F:17% & aged animals in C: 54%) for 3 days changes in short-term HPC & amygdala memory or in young animals Nutrients 2022, 14, 4137 11 of 36 Table 2. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Model Learning/Memory Neuroplasticity Other Pathways Refs. ↑ inflammation in Mixed HFD (F: microglia of Rat (♂; 3 m & 60.3% & C: 21.3%) - - young & old [108] 24 m) vs. CD (F:17% & C: 54%) for 3 days animals in HPC & amygdala Short periods (>2 weeks and ≤2 months) Mixed HFD (F: ↓ GluA2, PSD95, 42% & C: 25%) or synaptophysin, & TrKB ↓ glucocorticoid Young animals Rat (♂; 3 w) - receptor in HPC. No [109] CD (F: 4% & C: receptor in HPC 50%) for 7 w changes in BDNF ↓ response to leptin HFD (F: 60%) vs. induction of Mouse (♂; 3 w) CD (F: 6.55%) for - AMPAR-mediated synaptic - [110] 8w transmission in HPC neurons HFD (F: 21.2% & C: 22.5% by ↓ neurogenesis weight) & CD Impaired memory Synaptic loss in CA1-HPC and ↑ Mouse (♂; 3 w) neurons [111] (F:3.6% & C: (NOR) inflammation in 28.8% by weight) HPC for 6 w HFD (F: 60% & C: 20%) calorically matched or ad ↓ spine density in PFC in Mouse (♂; 8 w) - - [112] libitum vs. CD (F: both HFD protocols 13% & C: 58%) for 3 w. Saturated HFD (F: Impaired memory ↓ LTP in HPC. ↓ GluA1 phosphorylation & ↑ INS resistance in Mouse (♂; 4 w) 60%) vs. CD (F: HPC [32] 6.55%) for 6–7 w (MWM) palmitoylation in HPC ↓ BDNF, phosphoTRKB, Saturated HFD (F: Impaired memory phosphoCREB & glutamate Mouse (♂; 4 w) 60%) vs. CD (F: - [113] 6.55%) for 6–7 w (NOR & NLR) metabotropic receptors in HPC SOLF (60% CD + 40% saturated ↓ GluN2A & 2B by oil-enriched food) SOLF/UOLF in young Mouse (♂; or UOLF (60% Impaired memory animals (no changes in old). - [102] 5 & 8 w) CD + 40% (Y-maze) by SOLF unsaturated ↓ LTP & ↑ LTD by SOLF in oil-enriched food) young animals for 8 w Impaired learning Rat (♂; 6 w) HFD (F: 40%) vs. & memory - ↑ ER stress & INS [114] CD for 6 w resistance in HPC (MWM) HFD (F: 40% & C: Rat (♂; 7 w) 40%) vs. CD (F: - ↓ BDNF in PFC ↑ ER stress in PFC [115] 12.5% & C: 62.9%) for 8 w HFD (5000 Impaired learning kcal/kg) vs. CD ↓ synaptotagmin1 & Rat (♂; 2 m) & memory - [116] (3600 kcal/kg) for synapsin 1 8w (MWM) HFD (F: 21.2% & Impaired C: 61.3% by long-term ↓ LTP in CA1-HPC. ↓ cfos, weight) vs. CD (F: memory (FC). No synaptophysin, CaMKII & Mouse (♂; 6–8 w) ↑ oxidative stress [117] 7.5% & C: 75.1% changes in IV, calcineurin A in HPC. by weight) for 4 short-term No changes in BDNF or 7 w memory (NLR) HFD (F: 45%) vs. Impaired - INS resistance in Mouse (♂; 8 w) CD (F: 10%) for 2 short-term brain [118] m memory (T-maze) HFD (F: 58% & C: Impaired learning Adult animals Rat (♂; adult) 17%) vs. CD for 5 & memory - - [119] w (MWM) Nutrients 2022, 14, 4137 12 of 36 Table 2. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Model Learning/Memory Neuroplasticity Other Pathways Refs. HFD (F: 20% & C: 48% by weight) Rat (♂) vs. CD (F: 5% & - No changes in LTP in - [120] C: 47% by weight) DG-HPC for 8 w Mixed HFD (F: Rat 39%) vs. CD (F: - - ↑ oxidative stress [121] 13%) for 2 m Saturated HFD (2 % cholesterol + 10 Impaired memory ↑ microglia Rat (♂; 16 m) % trans coconut Dendritic loss in HPC activation & [101] (water radial arm inflammation in oil) vs. soybean maze) HPC oil (12%) for 8 w Mixed HFD (F: No changes in Mouse (♂) 45% & C: 45%) vs. memory (Y-maze - - [122] CD (F: 10% & C: 70%) for 8 w & NOR) Long periods (>2 months) Altered Mixed HFD (F: antioxidant 60% & C: 20%) vs. Impaired memory defense, ↑ Young animals Mouse (♂; 4 w) SD (F: 10% & C: ↓ BDNF in HPC & CTX oxidative stress, [123] (Y-maze & MWM) inflammation & 70%) for 14 w INS resistance in HPC & CTX HFD (F: 59.28%) Impaired memory INS resistance & Rat (♂; 5–6 w) vs. CD (F: 19.77%) ↓ spine density & LTP in ↓ mitochondrial [124] for 16 w (MWM) HPC function in brain Mixed HFD (F: ↑ surface GluA1 in HPC. No 60% & C: 20%) vs. Impaired learning changes in total levels or Rat (♂; 6 w) - [125] CD (F: 13% & C: (FC) 58%) for 6 m GluN2B ↓ GluN1/2A, GluA1, PSD95 Mixed HFD (F: Impaired memory & synaptophysin. No Mouse (♂; 6 w) 60%) vs. CD (F: - [126] 12.6%) for 16 w (Y-maze) changes in GluN2B or GluA2 HFD (F: 22% by weight) vs. CD (F: ↑ inflammation in Mouse (♂; 6 w) - - HPC & CTX & [127] 6% by weight) for gliosis in CTX 16 w Mixed HFD (F: ↓ PSD95. No changes in Rat (♂; 7 w) 45%) vs. CD (F: - - [128] 6%) for 17 w synaptophysin No changes in short-term Saturated HFD (F: (Y-maze), No changes in 59% & C: 26%) vs. long-term & Mouse (♂; 8 w) CD (F: 11% & C: - microglia [129] 59%) for 8, 16, 24 learning (MWM). activation in HPC & 28 w Impaired & CTX cognitive flexibility Mixed HFD (F: Impaired memory ↓ branching, spine density, ↑ microglia Mouse (♂; 8 w) 60% & C: 20%) vs. PSD95, spinophilin, & activation, [130] CD (F: 10% & C (MWM, NOR & inflammation & 70%) for 46 w Y-maze) synaptophysin in HPC iNOS in HPC Mixed HFD (F: Impaired learning ↑ inflammation & Mouse (♂; 8 w) 60%) vs. CD for & memory - INS resistance in [131] 16 w (MWM) HPC & CTX Mixed HFD (F: ↑ oxidative stress Mouse (♂; 45%) vs. CD (F: - ↓ synaptophysin in HPC & INS resistance, [132] 8–10 w) 10% & C: 60%) for & ↓ neurogenesis 13 w in HPC Nutrients 2022, 14, 4137 13 of 36 Table 2. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Model Learning/Memory Neuroplasticity Other Pathways Refs. Mixed HFD (F: No changes in 60%) vs. CD (F: Impaired learning Mouse (♀; 2 m) 10%) for 4 m. & memory ↓ BDNF in HPC inflammation or [95] Intervention: 16 (MWM & FC) mitochondrial m with CD function in HPC HFD (F: 45%) vs. Impaired memory Adult animals Mouse (♂) CD (F: 10%) for ↓ LTP in HPC - [96] 17 w (T-maze) HFD (F: 60% by Gut dysbiosis, ↑ weight) vs. CD (F: Impaired memory ↓ BDNF, synaptophysin, & inflammation, & Mouse (♂; 9 w) PSD95 in HPC & PFC microglia [97] 5% by weight) for (NOR & NLR) activation in HPC 13–15 w & PFC ↑ inflammation, Mixed HFD (F: microglia 60% & C: 20%) vs. Impaired memory ↓ PSD95 & SNAP23 in HPC activation, Mouse (♂; 9 w) CD (F: 10% & C: & CTX oxidative stress, [98] (MWM & Y-maze) INS resistance & 70%) for 24 w Aβ in HPC & CTX Gut dysbiosis, ↑ ↓ PSD95, synaptophysin, inflammation, HFD (F: 55%) vs. Impaired memory thickened of post synaptic Mouse (♂; 12 w) CD (F: 13%) for microglia [99] 15 w (NOR & NLR) density, & ↑ width of activation, & INS synaptic cleft in CA1-HPC resistance in CA1-HPC Mixed or saturated HFD effects were classified according to experimental approach, taking into account exposure time, days (≤2 weeks), short (>2 weeks and ≤2 months) or long (>2 months) periods, sex, and age classified as young and adult (≤2 months, >2 months). Search terms used were as follows: “high fat diet” AND “learning”, “memory”, “synaptic plasticity” OR “AMPAR”. Only studies with rodents were included. Excluded were experimental models of maternal exposure. Percentage fats, carbohydrates, and proteins are relative to total energy unless otherwise indicated. Table abbreviations (used for the first time in this table) are as follows: Aβ: amyloid-β; DG: dentate gyrus; iNOS: inducible nitric oxide synthase; and SNAP23: synaptosome-associated protein 23. 3.2. Cognition Studies with Polyunsaturated Fats It is widely accepted that dietary unsaturated fats are healthy in contraposition to saturated fats. For instance, memory in adult mice was impaired after exposure to a saturated HFD, but not to an isocaloric diet with polyunsaturated fatty acids (PUFAs) [100]. However, it is important to differentiate between the unsaturated fats since their effects on the body differ. The most abundant omega-3 (ω-3) and omega-6 (ω-6) PUFAs in the brain are docosahexaenoic acid (DHA; 22:6) and araquidonic acid (AA; 20:4), respectively, mostly obtained from diet or synthesized in the liver from dietary alpha-linolenic acid (ALA, 18:3) and linoleic acid (LA, 18:2), respectively. The most abundant monounsaturated fatty acid (MUFA), oleic acid (OA, 18:1), is found in food and in the mammalian brain [133]. Several studies have been conducted to clarify the role of the different unsaturated fats in human cognition. A systematic review showed that diet supplementation with ω-3 PUFAs is associated with cognitive improvement in patients with AD, but only at early stages of the disease when the impairment is very mild [134], and it is not clear whether ω-3 or ω-6 PUFAs can prevent cognitive decline in healthy elderly people [135]. Moreover, ω-3 supplementation during pregnancy, breastfeeding, and the early years of life did not seem to improve cognitive skills in children. Additionally, diet supplementation with DHA did not seem to improve working memory performance in healthy young adults [136]. However, combined supplementation with ω-3, carotenoid and vitamin E or with long- chain ω-3 fatty acids alone exerted positive effects on working memory tasks in cognitively healthy older adults [137,138] and in patients with MetS (and with schizophrenia) [139]. Furthermore, virgin olive oil, which is rich in OA, shows anti-aging and neuroprotective effects [80], although this seems to be due, not to OA per se, but to other minor components present in extra-virgin olive oil, such as polyphenols (with antioxidant activity) [140]. Interestingly, adherence to the MedDiet (especially rich in both OA and ω-3) reduces the Nutrients 2022, 14, 4137 14 of 36 risk of mild cognitive impairment, progression to dementia, and even the AD mortality rate (for a review, see [141]). The MedDiet, including equivalent nutritional interventions with different food bases carried out in non-Mediterranean countries (e.g., Japan or Australia), has been associated with improved learning and memory parameters during aging. Since studies in humans are complex in terms of implementation and of consistent results with specific nutrients, animal studies are key to addressing nutrition questions. In older mice, the daily administration of an ω-3 mix, but not olive oil, for 2 months improved cognitive performance [142], while perilla oil (rich in ω-3) more than corn oil (rich in ω-6) improved spatial learning and memory in rats [143]. A study to test 14-day plant oil supplementation showed attenuated deleterious effects in different animals previously brain-injected with Aβ [144]. Interestingly, only perilla oil slightly improved cognitive performance, while ω-6 supplementation seemed to potentiate the harmful effects of Aβ42 [145]. Olive oil supplementation for 6 months improved cognitive performance in a tauopathy animal model [146], although, since virgin olive oil contains different micronutrients, it cannot be affirmed that the beneficial effects were exclusively due to OA, and no studies exist specifically of OA. 3.3. Synaptic Function and Neuroplasticity with Mixed and Saturated Fats Strong evidence exists for HFD detrimental effects on synaptic function. Mixed or saturated HFD (7 days or 46 weeks) reduced branching and spine density in the HPC and PFC in both adolescent and aged animals [101,124]. In adult mice, lesser post synaptic density and a wider synaptic cleft were reported for both acute and long-lasting HFD exposure [93,99]. In line with in vivo findings, palmitic acid (PA; 200 µM) reduced dendritic length and arborization in cultured HPC neurons, but the effects of PA were counteracted when combined with the ω-3 DHA (125 µM) [107]. Similarly, DHA (200 µM) co-exposure prevented PA-(200 µM) mediated synaptic loss and dendritic blebbing [147]. Taken together, those results suggest that the intake of unsaturated and saturated fatty acids (in a proportion close to 1:1) could reverse deleterious cognitive effects, and may explain why mixed HFD sometimes do not impair memory [122]. Moreover, numerous studies have demonstrated that both PA treatment and a mixed or saturated HFD inhibit LTP in HPC slices [96,102–104,117,124], whereas no effect has been observed in the dentate gyrus or in long-term depression (LTD) [104,120]. LTD, as the opposing process to LTP, is an activity-dependent reduction in synaptic strength that underlies surface elimination of AMPARs [20]. In another study, saturated oil-enriched food potentiated LTD and inhibited LTP more strongly than unsaturated oil-enriched food [32], suggesting that only saturated fats are detrimental. This enhancement in LTD may be associated with spine shrinkage and AMPAR synaptic loss. In vitro, treatment with PA reduced AMPA sensitivity in cortical neurons, while no changes were observed for NMDA [147], suggesting that PA may specifically reduce AM- PAR synaptic levels. It was also demonstrated that PA-dependent morphological changes (cell body size) in HPC neurons are mediated by phosphoinositide 3-kinase (PI3K) [147]. The fact that this kinase phosphorylates the plasma membrane (PM) phosphoinositide PI(4,5)P2 , a lipid that directly binds and stabilizes surface GluA1 [148], suggests that PA may downregulate the synaptic levels of GluA1 subunit through that signaling pathway. In vivo, early HFD exposure induced downregulation of the Ca2+ -impermeable GluA2 subunit and its scaffold postsynaptic density protein 95 (PSD95) in the HPC [109]. Addi- tionally, in young animals, HFD exposure (rich in saturated fats) increased PA deposition in the HPC, leading to hyper-palmitoylation and hypo-phosphorylation of GluA1, reducing its recruitment at the PM and inhibiting AMPAR-mediated currents [32]. In adult ani- mals on a long-term mixed HFD, surface GluA1 levels in the HPC were increased, but no changes were observed in total levels [125]. As explained above, enrichment of synaptic CP-AMPARs (mainly GluA1 homomers) has been linked to pathological conditions by contributing to excessive Ca2+ influx, which ultimately causes synaptic dysfunction [20]. It is unknown whether this long-term increase in surface GluA1 may be a consequence of Nutrients 2022, 14, 4137 15 of 36 deregulation in scaffold proteins like PSD95, or in their trafficking towards the PM. Figure 1 depicts mixed and saturated HFD deregulation of AMPARs in the HPC. Figure 1. Mixed and saturated high-fat diet (HFD) deregulation of AMPARs in the hippocampus (HPC). In normal conditions, glutamate release induces activation of ionotropic α-amino-3-hydroxy- 5-methyl-4-isoxazolepropionic acid receptors (AMPARs), both GluA1-GluA1 homomers and GluA1- GluA2 heteromers, which mediate fast excitatory synaptic transmission. Under neuroplasticity paradigms like long-term potentiation (LTP) and long-term depression (LTD), AMPAR levels in the post-synaptic zone (PSZ) increase or decrease by exocytosis or endocytosis, respectively, or through changes in their lateral diffusion, mainly controlled by phosphorylation and dephosphorylation. An intake of saturated HFD decreases LTP, enhances LTD, and reduces total GluA2 and synaptic GluA1 levels. This decrease in GluA1 may be a consequence of increased palmytoilation mediated by palmitic acid (PA) and insulin (INS) and decreased phosphorylation, and by a decline in the levels of auxiliary and scaffold proteins. All these processes may impair trafficking of GluA1 towards the plasma membrane (PM). Moreover, PA-induced phosphorylation of PI(4,5)P2 (also called PIP2 ) by phosphoinositide 3-kinase (PI3K), a protein kinase activated by INS, may compromise surface GluA1 stabilization, and decayed GluA1 synthesis, mediated by brain-derived neurotrophic factor (BDNF) through the mammalian target of rapamycin (mTOR), may downregulate both total and synaptic levels. Altogether, the outcome is synaptic dysfunction and learning and memory impairment. Other figure abbreviations are as follows: Ca2+ : calcium ion; PIP2 : phosphatidylinositol (4,5)-bisphosphate; PIP3 : phosphatidylinositol (3,4,5)-trisphosphate. Image created with Biorender.com. The expression of other glutamate-type receptors (GluN1, 2B, and 2A) and of pre- and post-synaptic markers was frequently reduced by a mixed HFD, with PSD95 seem- ing to correlate better with impaired activity-dependent neuronal plasticity and memory deficits [93,97–99,102,109,126,128,130]. Like GluA1, the palmitoylation of other synaptic proteins plays an important role in regulating their membrane localization and AMPAR trafficking, and in controlling neuronal development, neurotransmission, and synaptic plasticity [149]. It would be interesting to test whether excessive palmitoylation of these proteins could underlie HFD-induced post-synaptic damage, as has been proved for neu- rodegenerative diseases. Nutrients 2022, 14, 4137 16 of 36 Mixed and saturated HFD-induced impairment is also associated with changes in other neuroplasticity-related factors, such as decreased BDNF [93,95,97,106,113,115,123]. The fact that acute exposure to an HFD leads to changes in BDNF levels suggests that the alterations may be a direct cause of glutamatergic synaptic dysfunction. Additionally, and as explained above, it should be noted that this decrease is only detected for the WD after long-term exposure, suggesting that a greater amount of saturated fats correlates with a greater impact on BDNF levels. Moreover, therapeutic approaches that rescue BDNF signaling (physical exercise, calorie restriction, and intermittent fasting) have been associated with cognitive improvement (for reviews, see [150,151]). 3.4. Synaptic Function and Neuroplasticity with Polyunsaturated Fats According to the observed effects of these fatty acids on cognition, a mix of ω-3 PU- FAs supplementation in aged mice for 2 months increased neurogenesis and dendritic arborization of newly generated HPC neurons [142]. Moreover, ω-3 but not ω-6 supplemen- tation increased dendritic spine density and the expression of different synaptic proteins in the HPC [143,152], while ω-3 supplementation in rat dams during pregnancy and lacta- tion increased the dentate gyrus LTP of the pups [153], while ω-3 deficiency in pups for 5 months after weaning reduced LTP in the CA1-HPC [154]. Regarding the expression of glutamate receptors, effects driven by the different fatty acids correlate with cognitive and synaptic function outcomes. ω-3 or perilla oil sup- plementation, compared to ω-6-rich diets, increased AMPARs in the HPC and reversed aging-mediated depletion of AMPARs in different brain regions [143,145,152,155]. ω-3 supplementation also increased BDNF expression and reduced apoptosis and astrocy- tosis [142,144]. In contrast, olive oil did not change total AMPAR expression or GluA1 phosphorylation [145,146]. Moreover, in mice pups, ω-3 deficiency for 5 months after weaning reduced GluA1 and GluN2B in HPC synaptosomes [154]. Altogether, those studies suggest that ω-3 PUFAs improve synaptic function, while ω-6 PUFAs have no or even a negative effect, while the few studies on the effects of OA alone do not allow any conclusions to be drawn. Figure 2 depicts the role played by ω-3 in protecting against neurodegeneration and aging. Figure 2. Protective role of omega 3 (ω-3) against neurodegeneration. In animal models of aging or neurodegeneration, diet supplementation with ω-3 reduced apoptosis and astrocytosis, and enhanced neurogenesis, dendritic arborization, spine density, and levels of BDNF, AMPARs, and scaffold proteins, like postsynaptic density protein 95 (PSD95), in the HPC. The fact that ω-3 deficiency reduced LTP in aged mouse CA1-HPC suggests that ω-3 could also improve activity-dependent synaptic plasticity, contributing to its protective role in cognition. Image created with BioRender.com. Nutrients 2022, 14, 4137 17 of 36 3.5. Other Mecanisms of Hippocampal Damage with Mixed and Saturated Fats Altered brain insulin signaling is also an important hallmark in mixed or saturated HFD-mediated deficits [32,94,114,124,131,132]. PA treatment induced over-activation of INS signaling [147] and INS resistance [32] in HPC neurons. In contrast, metformin treat- ment attenuated INS resistance and restored learning behavior [120,124,127]. Similarly, an HFD caused leptin resistance, blocking leptin-induced potentiation of AMPAR-mediated synaptic transmission in HPC neurons [110]. Therefore, anti-diabetic treatments, which at- tenuate cognitive deficits in high-energy-fed rats, could be interesting prophylactic options for patients with MetS. Mixed or saturated HFD-mediated synaptic dysfunction of the HPC has also been associ- ated with other mechanisms: increased oxidative stress [94,98,117,121,132], mitochondrial dysfunc- tion [124], ER stress [114,115,156], decreased glucose transport [132], reduced neurogenesis [111,132], metabolism and gut microbiota alterations [93,97,100], glucocorticoid axis defects [103,109], and microglia activation and neuroinflammation [92,93,97–99,101,105,107,108,111,117,127,129]. For in- stance, central administration of an IL-1 receptor antagonist or intraperitoneal administration of an anti-TNF-α antibody rescued mixed HFD-induced cognitive deficits [92,105], systemic glucocorti- coid receptor antagonist administration alleviated LTP and memory impairments mediated by a saturated HFD [103]. However, it is still unclear how those mechanisms contribute to HFD-mediated synaptic dysfunction and cognitive decline. Furthermore, the role of exosomes in neurodegenerative diseases is a very exciting emerging field, although the mechanisms underlying exosomes-mediated neuroplasticity and AMPAR regulation are still being uncovered. It has been described that exosomes iso- lated from palmitate-stimulated microglia induced an immature dendritic spine phenotype in hippocampal neurons, probably by enhancing neuroinflammation. Moreover, intranasal administration of neural stem cell-derived exosomes rescued memory in HFD mice [113]. Such results suggest that exosomes may be regulating AMPAR levels, synaptic plasticity, and cognition. In conclusion, exposure to a saturated HFD causes memory impairment, synaptic dys- function, and alterations in AMPAR trafficking, most especially in young people and aged. However, unsaturated fatty acids, particularly ω-3, have some benefits at the synaptic level, which could improve cognitive processes in neurodegenerative diseases and counteract the deleterious effects of saturated fatty acids. 4. High-Sugar Diet Findings exclusively focused on HSD are also revealing the specific effects of certain nutrients on cognition. High consumption of (simple) sugars is the other major factor that not only contributes to obesity worldwide, but is also associated with other metabolic diseases like T2D. Yet there are few human studies on HSD effects at the cognitive level [40]. In adolescents, no significant correlation was found between additional sugar intake and memory performance, while negative and positive associations were detected for saturated fatty acids and for ω-3 consumption [86]. Likewise, no association was observed in adults [87], while in middle-aged and older people, a greater intake of total sugars, added sugars, and sugar-sweetened beverages correlated with poorer cognitive function [157]. In all, strong evidence obtained from experiments in animal models enables the conclusion that an HSD, irrespective or not of weight gain, leads to cognitive impairment. Table 3 summarizes animal studies of the effects of an HSD. 4.1. Cognition Studies in Animal Models The form in which added sugar is consumed, as a beverage or as solid food, seems to be independent of its potential to impair cognition. Both sucrose- and fructose-sweetened beverages induced memory deficits in animal models [162,163,167,171], especially in males [160], even when exposure was restricted to 2 h per day [159]. These deficits may be quite permanent, since impairment was reported even one month after sweet solution withdrawal [166]. Similarly, short-term exposure (8 days) to a simple carbohydrate-based Nutrients 2022, 14, 4137 18 of 36 diet (mainly sucrose) was enough to damage HPC-dependent memory in a way comparable to a saturated HFD [100]. Especially interesting is the fact that males seem to be more at risk of HSD-induced cognitive deficits, and it is likely that endogenous estrogens may protect memory in females [170]. No significant alterations in working and spatial memory were observed in middle-aged female mice exposed to an HFru solution for 12 weeks [170]. Overall, however, the sex-specific mechanisms of diet-based impairments in cognition are still poorly understood. Table 3. HSD effects on synaptic function and cognition in animals. Species, Sex, Age Synaptic Function, Exp. Approach Diet Model Learning/Memory Neuroplasticity Other Pathways Refs. High sucrose HSu diet vs. CD ↓ BDNF and synaptophysin Young animals Rat (♂; 3 w) - - [158] for 8 w in brain HSu solution (10%) 2 h/day vs. Impaired learning Rat (♂; 3 and 8 w) 0.1% sodium and memory - - [159] saccharin solution (MWM) for 4 w HSu solution Impaired memory Rat (♂and ♀; 4 w) (10%) 2 h/day vs. (NLR; more - - [160] water for 2 & 4 w deficits in ♂) HSu solution ↑ GluA1 phosphorylation in Rat (♂; 8 w) (32%) vs. water - dorsal HPC at 3 days and ↓ - [161] for 3, 5 or 10 days at 5 and 10 days HSu solution Impaired memory No changes in Rat (♂; 12 w) (35%) vs. water ↓ LTD in CA1-HPC (no [162] (NLR and NOR) changes in LTP) metabolic profile for 9 w in HPC Impaired memory No changes in HSu solution ↑ GluA1 and GluN1 protein Adult animals Rat (♂; 4 m) (35%) vs. water (MWM and oxidative stress or [163] for 9 w Y-maze) levels in HPC inflammation in HPC High fructose Microglia activation, ↑ HFru (35%) vs. - - inflammation, ↓ Young animals Mouse (♂; 5 w) CD for 8 w neurogenesis, and [164] neuronal loss in HPC INS resistance and microglia HFru (60%) vs. - ↓ BDNF and PSD95 in HPC Rat (♂; 6 w) CD for 12 w activation, and ↓ [165] neurogenesis in HPC Astrocytosis, ↓ HFru solution Impaired spatial neurogenesis, ↑ Rat (♂; 6 w) (10%) vs. water memory (Barnes - inflammation, [166] for 12 w maze) and in HPC and PFC Alterations in HFru solution Impaired memory ↓ phosphoTrKB and metabolism, Rat (♂; 2 m) (15%) vs. water synaptophysin. No changes mitochondrial [167] for 8 w (Barnes maze) in BDNF in HPC function and INS resistance in HPC INS resistance and ↓ inflammation in HFru solution HPC with 10% of Rat (♂; 12 w) (10 % or 60%) vs. - - HFru. No [168] water for 9 w changes in Ins and ↑ inflammation with 60% of HFru Nutrients 2022, 14, 4137 19 of 36 Table 3. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Diet Model Learning/Memory Neuroplasticity Other Pathways Refs. HFru solution Impaired memory INS resistance in Adult animals Rat (♂) (15%) vs. water - HPC [169] for 6 w (Barnes maze) HFru solution No changes in Mouse (♀; 9 m) (10%) vs. water spatial memory - ↓ antioxidant [170] for 12 w defense in PFC (Y maze) High sucrose vs. high fructose Impaired memory in young animals ↑ inflammation in HSu or HFru with HFru young animals Young animals Rat (♂; 4 and 9 w) solution (11%) vs. (Barnes maze). - with HFru. No [171] water for 30 days No changes in changes in adults adults or with or with HSu HSu Simple carbohydrates HC (simple C: Gut dysbiosis. No 30%) vs. CD Impaired memory No changes in BDNF in changes in Adult animals Rat (♂) (simple C: 16%) HPC [100] (NLR) inflammation in for 8 days HPC ↑ expression of HC (simple C: neurodegenera- 36% weight) vs. tion genes, Mouse (♂; 22 w) - - inflammation, [172] CD (simple C: mitochondrial 12%) for 10 w function, and oxidation in HPC HSD effects were classified according to experimental approach, taking into account sugar type (high sucrose, high fructose, high sucrose vs. high fructose, or simple carbohydrates), sex, and age classified as young or adult (≤2 months, >2 months). Search terms used were as follows: “high sucrose” OR “high fructose” AND “learning”, “memory”, “synaptic plasticity” OR “AMPAR”. Only studies with rodents were included. Excluded were experimental models of maternal exposure and pathological conditions. Carbohydrate percentages are relative to total energy unless otherwise indicated. 4.2. Synaptic Function and Neuroplasticity As far as we are aware, only one study has explored the direct consequences of an HSD on synaptic function using LTP/LTD paradigms. Unexpectedly, no changes in synaptic plasticity measured by the LTP paradigm were detected in CA1-HPC pyramid synapses af- ter 9 weeks of HSu intake; however, LTD was decreased in the temporoammonic pathway, a projection that connects the entorhinal cortex to CA1-HPC [162]. Further research is needed to explore this issue, since learning and memory deficits suggest synaptic dysfunction. Several studies, nonetheless, have highlighted changes in neuroplasticity-related pro- teins. Acute exposure to HSu increased HPC GluA1 phosphorylation after 3 days and reduced it after 5–10 days [161], indicating that HSu modifies synaptic levels, while longer- term exposure to HSu increased GluA1 total levels [163]. This effect may be explained by HSu-mediated hyperactivation of mTOR [173] and by aberrant GluA1 synthesis. Re- garding BDNF, longer-term exposure to HSu or HFru decreased BDNF levels [158,165] and phosphorylation of its receptors [167], while no changes were detected over shorter periods [100], as happens with a WD. 4.3. Insulin Resistance Daily fructose consumption induced INS resistance in the HPC [167–169], while anti- diabetic treatment reversed this effect and enhanced HFru-induced downregulation of BDNF and other synaptic markers in the HPC [165]. Furthermore, added sucrose in a regular diet resulted in a pre-diabetic state, characterized by hyperinsulinemia and peripheral INS resistance [163]; however, this effect has not been studied at brain level. Nutrients 2022, 14, 4137 20 of 36 4.4. Other Mechanisms Mitochondrial dysfunction, reduced neurogenesis, microglia activation, and gut mi- crobiota alterations have been associated with an HSD [100,165–167]. Moreover, while HSu exposure produced no effect on inflammation and metabolism [100,163,171], HFru was clearly deleterious [166,168,171]. Neuroinflammation and neuron loss induced by HFru were prevented by short-chain fatty acids, which may exert their protective effects by regulating intestinal homeostasis [164]. Summarizing, with HSD-induced synaptic dysfunction and memory impairment, especially in males and in aging individuals, it would seem that fructose causes more HPC damage than sucrose. However, no study has analyzed HSD outcomes beyond 12 weeks. Since sugar and sweetened beverage intake is higher in adolescents and young adults than in any other age group, it would be interesting to analyze whether an early- life HSD exacerbates age-related impairments in synaptic function and causes late-life cognitive decline. 5. Ketogenic Diet The ketogenic, or keto, diet (KD), high in fats and low in carbohydrates, is based on limiting glucose intake and inducing liver production of ketone bodies (KBs)—acetoacetate, acetone, and β-hydroxybutyrate—and their uptake as an alternative energy source by the brain. The evidence is that KD is effective in reducing or delaying cognitive impairment, in both murine models and human studies. Table 4 summarizes details of human and animal studies of KD and KB supplementation. Table 4. KD and KB supplementation effects on synaptic function and cognition in humans and animals. Species, Sex, Age Synaptic Function, Exp. Approach Diet Model Learning/Memory Neuroplasticity Other Pathways Refs. Ketogenic diet KD (F: 60%, C: 15% & P: 25%) vs. No changes in Humans Human (♂and ♀; CD (F: 20%, C: cognitive - - [174] 18–40 y) 55% & P 25%) for performance 3w Human (♂and ♀; KD (C: 5–10%) vs. Improved paired CD (C: 50%) for - - [175] ~70 y) 6w associate learning KD (F: 90.5%, C: No differences in 0.3% & P: 9.1%) learning (Hebb Young animals Mouse (♂; 3 w) vs. CD (F: 13%, C: Williams Maze) or - - [176] 67% & P: 20%) for memory (passive 2w avoidance test) KD (F: 75.1%, C: Impaired learning 3.2% & P: 8.6%) Mouse (♂; 3 w) vs. CD (F: 7.1%, (MWM) but no - - [177] C: 63.2% & P: differences in 18.3%) for 5.5 w memory (NOR) KD (F: 78.8%, C: 0.8% & P: 9.5%) Impaired learning Rat (♂; 3 w) vs. CD (F: 10%, C: and memory - - [178] 49% & P: 23.4%) (MWM) for 1 m KD (F: 87% & C + No changes in short-term Rat (♂; 3 w) P: 13%) vs. CD - plasticity but ↓ LTP - [179] for 3 w magnitude KD (F: 92%, C: 3% & P: 5%) vs. CD No changes in No changes in short-term or Rat (3 w) - [180] (F: 12%, C: 65% & memory (FC) long-term plasticity P: 24%) for 2–3 w Nutrients 2022, 14, 4137 21 of 36 Table 4. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Diet Model Learning/Memory Neuroplasticity Other Pathways Refs. KD (F: 69%, P: ↑ transitory glia 24% & C: 0%) vs. No changes in activation in Rat (♂; 4 w) CD (F: 12%, P: - CA3-HPC at 1 w [181] 23% & C: 54%) for learning (MWM) (no changes 6w at 6 w) Improved KD (F: 90%, P: short-term 10% & C: 0%) vs. memory (Y-maze) ↑ GluA1 levels in HPC (no Rat (♂; 7–8 w) - [182] CD (F: 10%, P 10% but no changes in changes in GluA2) & C: 80%) for 3 w long-term memory (MWM) No changes in KD (F: 90%, C: 0% learning (MWM) Adult animals Mouse (♂; 3 m) & P 10%) vs. CD No changes in LTP - [183] (F: 10%, C: 80% & and memory P 10%) for 3 m (MWM and Y-maze) KD (F: 75.9%, C: 3.9% & P 20.1%) Improved Rat (86% ♂; 4 and vs. CD (F: 16.4%, memory - ↓ GLUT1 in PFC [184] 20 m) C: 64.9% & P (WM/BAT) 18.8%) for 12 w KD (F: 75.9%, C: ↓ expression of gria1, 2 and ↓ presynaptic Rat (♂; 4 and 3.9% & P 20.1%) 4, and other postsynaptic proteins in vs. CD (F: 16.4%, - [185] 20 m) C: 64.9% & P proteins in DG-HPC (no DG-HPC (no 18.8%) for 12 w changes in CA3) changes in CA3) Cyclic KD: KD (F: 90% & P: 10%) & CD (F: 13%, P: Improved Mouse (♂; 12 m) 10% & C: 77%) memory (place - - [186] alternate weekly; avoidance test vs. CD (F: 14%, P: and NOR) 24% & C: 62%) for 12 m No changes in KD (F: 77.1%, C: memory (RAWM) Mouse (5 m; AD 0.5% & P: 22.4%) Diseased animals vs. CD (F: 14%, C: but improved No changes in neural loss - [187] model and WT) 62.2% & P: 23.8%) motor function for 3 m (AD or WT animals) Improved ↓ Aβ, KD (F: 76%, C: 3% learning and microgliosis, Mouse (7 m; AD & P: 16%) vs. CD memory at 4 m (F: 12%, C: 65% & - inflammation and [188] model and WT) P: 23%) for 2 & (no changes at ↑ number of 4m 2 m; T and Barnes spines and maze tests) neurons in HPC Standard diet supplemented with ketone bodies KB solution (40 g of MCT) vs. placebo drink in a single session Improved Humans Human (♂and ♀; of 1 h under hypoglycemia- - - [189] ~15 y; T1D) hypoglycemic mediated conditions (tests memory deficits performed 1 h before & 1 h latter) BHB (0.9% weight/volume) Improved Human (♂and ♀; i.v., infusion vs. working memory - - 35–70 y; T2D) placebo (tests [190] (no changes in performed global cognition) 120 min latter) Nutrients 2022, 14, 4137 22 of 36 Table 4. Cont. Species, Sex, Age Synaptic Function, Exp. Approach Diet Model Learning/Memory Neuroplasticity Other Pathways Refs. Ketogenic formula (20 g of Human (♂and ♀; MCT in 36 g of Improved - - [191] 60–74 y) total F) or placebo working memory 90 min before tested Ketogenic Improved Human (♂and ♀; solution (MCT) executive - - [192] ≥55 y; MCI) daily or placebo function, memory, 6m and language Ketogenic formula (20 g of Improved in Human (♂and ♀; MCT in 35.9 g of ~73 y; mild-to immediate and - - [193] total F) daily or delayed logical moderate AD) memory placebo for 12 w vs. baseline Ketogenic solution (MCT) vs. placebo Improved Human (~74.7 y; cognitive solution (long mild-to moderate performance only - - [194] chain in ApoEε4— AD) triglycerides; tests subjects performed 120 min latter) BHB supplementation (60 mg/kg) for Young animals Mouse (♂and ♀; - ↑ BDNF levels in HPC [195] 8 w) 2 days (twice/day) via intragastric gavage MCT8 formula (5 % of octanoic triglyceride) or Improved No changes in PSD95 and MCT10 formula memory (NOR) synaptophysin in brain. ↓ ↑ INS signaling in Aged animals Rat (♂; 21 m) (5 % of decanoic with MCT10 (no [196] triglyceride) vs. changes with expression of brain CD (5 % MCT8) plasticity-related genes sunflower oil) for 8w BHB solution ↓ Aβ and Diseased animals Mouse (♂and ♀; (0.019 g/mL) - - inflammation in [197] 8 w; AD model) brain daily for 8 w BHB & ACA solution via Improved subcutaneous injection learning and ↓ Aβ and Mouse (4 m; AD ↑ LTP (no changes in WT) oxidative stress in [198] model and WT) (600 mg/kg/day memory (MWM & and NOR; no brain 150 mg/kg/day) changes in WT) daily for 2 m KE + BHB supplementation ↓ Aβ and (ketone esters: Improved phosphorylated Mouse (8.5 m; AD 21.5%; F: 8.2% C: memory (MWM - tau in CA1 and [199] model) 43.5% & P: 23.9%) CA3-HPC, vs. CD (F: 8.2% C: and FC) amygdala and 64.9% & P: 23.9%) CTX for 4 & 7 m ↓ Aβ in HPC and HBME (10, 40 & CTX. ↓ ROS and 80 mg/kg/d) Improved apoptosis under Mouse (♂; 7.5 m; daily intragastric learning and - [200] AD model) glucose administration vs. memory (MWM) deprivation in water for 2.5 m cultured neurons KD and KB supplementation effects were classified according to experiment approach, taking into account species (human, rodent), sex, rodent age classified as young (≤2 months), adult (>2 months and ≤20 months), or aged (>20 months), and diseased animals (Alzheimer disease (AD) models). Search terms used were as follows: “keto- genic diet”, “ketone body” OR “medium-chain triglyceride” AND “learning”, “memory”, “synaptic plasticity” OR “AMPAR”. Only studies with humans and rodents were included, and only mild cognitive impairment (MCI) Nutrients 2022, 14, 4137 23 of 36 and AD pathological conditions were included. Excluded were human case reports and experimental models of maternal exposure. Percentage fats, carbohydrates, and proteins are relative to total energy unless other- wise indicated. Table abbreviations (used for the first time in this table) are as follows: ACA: acetoacetate; BHB: β-hydroxybutyrate; g: grams; gria: gene-coding glutamate ionotropic receptor AMPA type subunit; HBME: 3-hydroxybutyrate methyl ester; KE: ketone esters; MCTs: medium-chain triglycerides; ROS: reactive oxygen species; WT: wild type; WM/BAT: working memory/bi-conditional association task; and y: years. 5.1. Cognition Studies in Humans The neuroprotective role of ketosis, which also holds for prolonged fasting, has been known for a century, since it reduces the frequency of epileptic seizures. The KD has more recently been tested in humans with AD and diabetes, with limited benefits reported in terms of cognitive and memory enhancement. Regarding AD, ketogenic formulas based on medium-chain triglycerides (MCTs) were associated with higher bloodstream ketone levels, improved short-term cognitive performance [194], and improved longer-term logical memory [192,193]. A very low carbohydrate diet that also increased ketone levels enhanced learning in older adults at high risk of AD [175]. In aged healthy subjects, a single intake of an MCT-based formula was associated with improved performance in working memory tasks [191]. Regarding diabetes, an MCT-based solution prevented hypoglycemia-mediated memory deficits in patients with type 1 diabetes (T1D) [189], while β-hydroxybutyrate (BHB) administration improved working memory in patients with T2D [190]. In contrast, in healthy non-overweight adults, 3 weeks of nutritional ketosis had no effect on performance of several cognitive tasks [174]. In recent years, the KD has gained popularity in the general population, whether self-administrated for memory enhancement or for other conditions, including weight loss, cancer, diabetes, and neurological and psychiatric disorders [201]. However, little is known about the transient symptoms reported during keto-adaptation and the possible side effects of long-term adherence to the KD, so more in-depth studies are needed before it can be recommended to healthy individuals. 5.2. Cognition Studies in Animal Models To better understand KD effects on cognitive performance, we reviewed findings ob- tained with rodents. In young animals, amygdala-dependent memory remained unaffected by the KD [180], with no differences or even impairments observed in HPC-dependent learning and memory tasks [176–178,181,182]. No changes in spatial learning were ob- served for a high-fat/moderate-protein diet [181], suggesting that protein imbalance may contribute to impaired cognition in some KD experimental models (as also described in [163–165,168,169]); this fact could also explain the increased mortality demonstrated for one of the KD paradigms with 75% fat and 8.6% protein (reduced by 10% compared to a control diet) [177]. In adult animals, KD exposure enhanced short-term memory, but no changes were detected for long-term memory [182,184]. Interestingly, an MCT-based formula or cyclic KD (alternated weekly with a control diet) diminished or prevented, re- spectively, memory decline in aged animals [186,196], as did different KB supplementation paradigms for AD models [188,198–200]. 5.3. Synaptic Function and Neuroplasticity The KD mechanism of action at the synaptic level remains unknown. However, KD anti-convulsant effects in epileptic patients suggest enhanced inhibition and/or limited excitability in the brain. Indeed, in an epilepsy model, KD conferred protection against focal generation of seizures, although not against seizure spread [202]. In healthy young rodents, the KD did not modify excitability or short-term plasticity, but it did reduce LTP magnitude in the dentate gyrus [179]. However, other studies failed to detect any change in short- or long-term HPC plasticity for the KD [180,183] or KB administration [198,203], supporting the absence of major alterations in cognition. In contrast, in an AD mouse model, the neuroprotective role of KBs improved synaptic plasticity [198], and, according to data Nutrients 2022, 14, 4137 24 of 36 from HPC slices, KBs improved recovery after an NMDA-mediated neuronal depression protocol that simulated neuronal injury [204]. One possible explanation for KB improvement of synaptic function may be the ability to induce neuroplasticity-related factors. BHB administration promoted BDNF expression in the HPC [195], while KD-fed mice showed higher HPC levels of GluA1 that correlated with enhanced memory [182]. However, other studies have reported reduced post-KD expression of the gria1, gria2, and gria4 genes (which encode GluA1, 2, and 4, respec- tively) in the dentate gyrus, as well as of other post-synaptic proteins, while no changes were observed in CA3 [185]; this would suggest subregional-specific modulation of the synaptic function by KD. The fact that reduced AMPAR expression may be explained by KD-mediated inhibition of the mTOR pathway [205] again highlights the importance of distinguishing between the effects of a specific KD (very heterogenous in composition) and KB supplementation. Since decanoic acid (a saturated fatty acid), but not KBs, has been shown to directly inhibit AMPARs (the mechanism by which seizures are controlled [206]), for AD it has been suggested that MCT supplementation might improve neuronal survival by blocking CP-AMPAR GluA1 homomers [207]. However, further studies are needed to confirm whether AMPAR synaptic level regulation underlies the beneficial effects of MCTs and/or KBs in neurodegeneration by contributing to homeostatic maintenance and delaying mem- ory deficits. 5.4. Insulin Resistance It is well known that KD feeding, low in carbohydrate, reduces blood glucose levels, which is accompanied by a decrease in circulating INS, finally reducing INS resistance [208]. Interestingly, in AD patients, INS infusion, without increasing glucose, improved mem- ory [209]. Moreover, an INS-degrading enzyme was identified as a new player in the removal of INS and Aβ from the brain, evidencing that both peptides were competing for the same enzyme [210]. Consequently, sustained INS levels, associated to INS resis- tance, enhanced Aβ deposition. In fact, experimentally induced INS resistance boosted β-amyloidosis in AD mouse models (as demonstrated, for example, by [211]). By contrast, BHB treatment of hippocampal neurons reduced Aβ-mediated toxicity in vitro [212], as KD or KBs supplementation did in vivo in mouse models of AD [188,197–200]. Additionally, KD or MCT supplementation increased INS signaling in the HPC of aged animals [196], specifically in neurons [213], and KD-fed adults showed lower levels of GLUT1, which transports glucose across the BBB, indicating that KBs decreased the dependence for glucose energetic metabolism [184]. It has been suggested that deleterious effects of INS resistance may result from metabolic stress, as neurons gradually lose access to glucose [214]. There- fore, KBs could provide neurons with an alternative fuel, reducing INS resistance-mediated brain damage and improving cognition in neurodegenerative diseases. In summary, KB and MCT diet supplementation shows better results than the KD in protecting synaptic plasticity and delaying cognitive impairment in aging individuals and in neurodegenera- tive and metabolic diseases. Since there is a lack of evidence of significant cognitive benefits after long-term KD intake in healthy populations, more studies are required to understand whether KBs or MCTs could act as adjuvant or prophylactic therapy to preserve memory in adolescents and adults. 6. Paleo(lithic) Diet The paleo(lithic) diet is the modern interpretation of a dietary pattern based on wild foods and animals, as assumed to be consumed by humans in the Paleolithic era. Based on macronutrient distribution, it is broadly composed of 20–30% protein, 30–45% carbo- hydrates and 30–40% fat. A more recent definition proposes a new 11-item paleo diet based on no consumption of processed foods; high consumption of fruits, nuts, vegetables, fish, eggs, and lean and unprocessed meats; and minimum content in grains, cereals, and legumes [215]. The absence of grains, cereals, legumes, and other cultivated products, such Nutrients 2022, 14, 4137 25 of 36 as olive oil and wine, is the main difference between the paleo diet and the MedDiet [141]. Despite anthropologists holding that our ancestors’ diet heavily influenced their neural complexity and brain size, the benefits of the paleo diet for cognition are poorly studied. High-protein diets (as an approximation to paleo diet) fed to animal models resulted in no performance differences in learning and memory tasks [216–218]. In overweight and T2D human patients, the paleo diet was associated with higher functional brain responses within the HPC [219,220], while in subjects with MetS, the paleo diet improved some cognitive functions and increased serum BDNF levels [221]. While episodic memory perfor- mance improved significantly after diet-induced weight loss, no differences were observed between paleo and control diets [219], suggesting that the memory and neuroplasticity effects of dietary interventions may be linked to calorie restriction or INS sensitivity. In short, the lack of in-depth studies means that no clear conclusions can be drawn as to the effects of the paleo diet at the synaptic and cognitive levels. So far, reported benefits may be improved metabolic health, as with other nutritional interventions. The growing popularity of the paleo diet, especially among young adults and athletes [215], would suggest a need to further study its long-term effects. 7. Conclusions As summarized in this review, the consumption of certain obesogenic food compo- nents, such as saturated fatty acids and simple sugars, more so than excessive calorie ingestion, contributes to the decline of both metabolic and cognitive health. Regardless of whether they result in weight gain, their systemic and local effects in the HPC produce neu- rological damage that leads to progressive learning and memory performance deterioration, enhancing the risk of neurodegenerative diseases, including AD. Animal models of HFD/HSD intake have provided insights to the impact of fats and sugars on synapsis and their correlation with cognitive decline. However, we found that heterogeneity in experimental approaches (non-specification or variations in the type and proportion of fats and sugars, non-isocaloric control and challenge diets, exposure times, palatability, etc.) prevent the drawing of clear conclusions. That said, we can affirm that an HFD (and especially when composed of saturated and trans fats and cholesterol) and an HSD (sucrose, fructose, and dextrose) produce memory decline at any age. In susceptible life stages—youth and old age—an HFD alone induces other negative effects, on neurodevelopment and maturation, and in exacerbating aging-related decay, respectively; an HSD (fructose more so than sucrose) also has negative effects, even if only consumed over a short period. Although a striking number of studies are carried out exclusively in males, a few studies demonstrate that females are more resistant to diet-mediated memory impairment, due both to a differential choice of calorie sources and the neuroprotective effects of estrogens. More comparative studies of the sexes would allow us to decipher the differential mechanisms at work in men and women, and to identify new cognitive improvement targets. As far as we are aware, no studies have analyzed whether HFD and HSD effects are additive, but we believe that both impair cognition by simultaneously harming different signaling pathways with the same outcomes. Figure 3 depicts the main hallmarks of HFD/HSD-mediated HPC damage, showing the correlation with memory and learning loss, even after short-term exposure. This is especially noticeable in reduced dendritic arborization, a widened synaptic cleft, narrowed postsynaptic density, and decreased PSD95 levels, while changes in other classically analyzed pre/post-synaptic markers are less consistent. Regarding the neuroplasticity marker BDNF, we suggest that reduced levels are a medium-term consequence of synaptic dysfunction, rather than a direct cause. The decrease in BDNF may also reduce GluA1 synthesis through the mTOR pathway. Furthermore, correlating perfectly with cognitive impairment is lower activity-dependent synaptic plasticity, exemplified by a decrease in LTP, whereas LTD is not always affected. Nutrients 2022, 14, 4137 26 of 36 Figure 3. Main hallmarks of HFD/high-sugar-(HSD)-mediated HPC damage. At the systemic level, both fat and sugar produce gut microbiota dysbiosis, which can exacerbate inflammation in the brain by enhancing blood-brain barrier (BBB) permeability. BBB damage, in turn, contributes to deregulating the transport of circulating orexigenic and anorexigenic hormones. In the HPC, local release of neuroinflammatory factors by activated microglia exacerbates neuronal damage. INS resistance, increased endoplasmic reticulum (ER), and oxidative stress also compromise neuronal function. In HPC neurons, HFD/HSD intake reduces dendritic arborization, spine density, and the PSZ, and widens the synaptic cleft. The glutamate neurotransmitter and its precursor, glutamine, are reduced, and also reduced over the short/medium-term are levels of AMPARs and of its scaffold protein PSD95. Finally, impaired activity-dependent synaptic plasticity (especially LTP) proves that AMPAR trafficking to the PM is also compromised by an HFD/HSD. Image created with Biorender.com. We believe that all those alterations converge in modifying synaptic AMPAR levels. Over the short/medium-term, AMPAR total and synaptic levels are reduced, and palmi- toylation and phosphorylation (both regulatory processes of GluA1 trafficking to the PM) are increased and decreased, respectively. However, long-term nutrition with HFD may enhance AMPAR synaptic levels, contributing to excessive Ca2+ influx and, ultimately, producing synaptic dysfunction as described for brain diseases. Therapeutic approaches and nutritional interventions are available that slow cogni- tive decline associated with aging and with neurodegenerative and metabolic diseases. Metformin can partially reverse HFD/HSD-mediated memory decline, which is especially interesting for patients with MetS, while ω-3, MCTs, or KBs (preferable to the KD) diet sup- plementation seems to improve cognitive performance in patients with AD and diabetes. At the molecular level, the MedDiet, with high ω-3 content (present in fish, seafood, soybean oil, nuts, and seeds), or diet supplementation with ω-3 blocks synaptic damage linked to aging and neurodegeneration and slows cognitive decline. Nutrients seem to mainly affect younger and aged people, so long-term nutritional health programs addressed to these age groups may produce the greatest benefits in terms of synaptic plasticity, learning, and memory. A final interesting note is that ω-3 fatty acids can reverse most of the molecular deleterious effects of saturated fatty acids in HPC synapsis; this is good news for the nutrition field, since well-balanced consumption of foods rich in saturated fats (cheese, butter, meat, etc.) combined with foods rich in unsaturated fats (vegetables oils, fish, seeds, etc.) does not appear to harm cognitive health. Author Contributions: Conceptualization, N.C. and R.F.; writing—original draft preparation, N.C., A.M., R.R. and R.F.; writing—review and editing, R.F.; supervision, N.C.; funding acquisition, N.C. All authors have read and agreed to the published version of the manuscript. Nutrients 2022, 14, 4137 27 of 36 Funding: This study was supported by the Spanish Ministry of Science and Innovation (MCIN) (PID2020-114953RB-C22 to NC co-funded by the European Regional Development Fund [ERDF]), the Biomedical Research Centre in Pathophysiology of Obesity and Nutrition (CIBEROBN). Institutional Review Board Statement: Not applicable. Informed Consent Statement: Not applicable. Data Availability Statement: Not applicable. Conflicts of Interest: The authors declare no conflict of interest. References 1. Smith, P.J.; Blumenthal, J.A. Dietary Factors and Cognitive Decline. J. Prev. Alzheimer’s Dis. 2016, 3, 53–64. [CrossRef] 2. Dye, L.; Boyle, N.B.; Champ, C.; Lawton, C. The Relationship between Obesity and Cognitive Health and Decline. Proc. Nutr. Soc. 2017, 76, 443–454. [CrossRef] [PubMed] 3. Nguyen, J.C.D.; Killcross, A.S.; Jenkins, T.A. Obesity and Cognitive Decline: Role of Inflammation and Vascular Changes. Front. Neurosci. 2014, 8, 375. [CrossRef] 4. Bramorska, A.; Zarzycka, W.; Podolecka, W.; Kuc, K.; Brzezicka, A. Age-Related Cognitive Decline May Be Moderated by Frequency of Specific Food Products Consumption. Nutrients 2021, 13, 2504. [CrossRef] [PubMed] 5. WHO. Obesity and Overweight. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and- overweight (accessed on 12 September 2022). 6. Loef, M.; Walach, H. Midlife Obesity and Dementia: Meta-Analysis and Adjusted Forecast of Dementia Prevalence in the United States and China. Obesity 2013, 21, E51–E56. [CrossRef] 7. Singh-Manoux, A.; Dugravot, A.; Shipley, M.; Brunner, E.J.; Elbaz, A.; Sabia, S.; Kivimaki, M. Obesity Trajectories and Risk of Dementia: 28 Years of Follow-up in the Whitehall II Study. Alzheimer’s Dement. 2018, 14, 178–186. [CrossRef] 8. Cournot, M.; Marquié, J.C.; Ansiau, D.; Martinaud, C.; Fonds, H.; Ferrières, J.; Ruidavets, J.B. Relation between Body Mass Index and Cognitive Function in Healthy Middle-Aged Men and Women. Neurology 2006, 67, 1208–1214. [CrossRef] 9. Coppin, G.; Nolan-Poupart, S.; Jones-Gotman, M.; Small, D.M. Working Memory and Reward Association Learning Impairments in Obesity. Neuropsychologia 2014, 65, 146–155. [CrossRef] 10. Gunstad, J.; Paul, R.H.; Cohen, R.A.; Tate, D.F.; Spitznagel, M.B.; Gordon, E. Elevated Body Mass Index Is Associated with Executive Dysfunction in Otherwise Healthy Adults. Compr. Psychiatry 2007, 48, 57–61. [CrossRef] 11. World Health Organization Diabetes. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed on 12 September 2022). 12. Moheet, A.; Mangia, S.; Seaquist, E.R. Impact of Diabetes on Cognitive Function and Brain Structure. Ann. NY Acad. Sci. 2015, 1353, 60–71. [CrossRef] [PubMed] 13. Palta, P.; Schneider, A.L.; Biessels, G.J.; Touradji, P.; Hill-Briggs, F. Magnitude of Cognitive Dysfunction in Adults with Type 2 Diabetes: A Meta-Analysis of Six Cognitive Domains and the Most Frequently Reported Neuropsychological Tests within Domains. J. Int. Neuropsychol. Soc. 2014, 20, 278–291. [CrossRef] [PubMed] 14. Reaven, G.M.; Thompson, L.W.; Nahum, D.; Haskins, E. Relationship between Hyperglycemia and Cognitive Function in Older NIDDM Patients. Diabetes Care 1990, 13, 16–21. [CrossRef] [PubMed] 15. Lamport, D.J.; Lawton, C.L.; Mansfield, M.W.; Dye, L. Impairments in Glucose Tolerance Can Have a Negative Impact on Cognitive Function: A Systematic Research Review. Neurosci. Biobehav. Rev. 2009, 33, 394–413. [CrossRef] [PubMed] 16. Komulainen, P.; Lakka, T.A.; Kivipelto, M.; Hassinen, M.; Helkala, E.L.; Haapala, I.; Nissinen, A.; Rauramaa, R. Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly Women. Dement. Geriatr. Cogn. Disord. 2007, 23, 29–34. [CrossRef] 17. Van den Berg, E.; Biessels, G.J.; de Craen, A.J.; Gussekloo, J.; Westendorp, R.G. The Metabolic Syndrome Is Associated with Decelerated Cognitive Decline in the Oldest Old. Neurology 2007, 69, 979–985. [CrossRef] 18. Yates, K.F.; Sweat, V.; Yau, P.L.; Turchiano, M.M.; Convit, A. Impact of Metabolic Syndrome on Cognition and Brain: A Selected Review of the Literature. Arter. Thromb. Vasc. Biol. 2012, 32, 2060–2067. [CrossRef] 19. Saklayen, M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018, 20, 12. [CrossRef] 20. Hanley, J.G. Subunit-Specific Trafficking Mechanisms Regulating the Synaptic Expression of Ca2+ -Permeable AMPA Receptors. Semin. Cell Dev. Biol. 2014, 27, 14–22. [CrossRef] 21. Jurado, S. AMPA Receptor Trafficking in Natural and Pathological Aging. Front. Mol. Neurosci. 2018, 10, 446. [CrossRef] 22. Guo, C.; Ma, Y.Y. Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders. Front. Neural Circuits 2021, 15, 711564. [CrossRef] 23. Wang, R.; Reddy, P.H. Role of Glutamate and NMDA Receptors in Alzheimer’s Disease. J. Alzheimer’s Dis. 2017, 57, 1041–1048. [CrossRef] [PubMed] 24. Keifer, J. Regulation of AMPAR Trafficking in Synaptic Plasticity by BDNF and the Impact of Neurodegenerative Disease. J. Neurosci. Res. 2022, 100, 979–991. [CrossRef] [PubMed] Nutrients 2022, 14, 4137 28 of 36 25. Whitcomb, D.J.; Hogg, E.L.; Regan, P.; Piers, T.; Narayan, P.; Whitehead, G.; Winters, B.L.; Kim, D.H.; Kim, E.; St George-Hyslop, P.; et al. Intracellular Oligomeric Amyloid-Beta Rapidly Regulates GluA1 Subunit of AMPA Receptor in the Hippocampus. Sci. Rep. 2015, 5, 10934. [CrossRef] [PubMed] 26. Miñano-Molina, A.J.; España, J.; Martín, E.; Barneda-Zahonero, B.; Fadó, R.; Solé, M.; Trullás, R.; Saura, C.A.; Rodríguez-Alvarez, J. Soluble Oligomers of Amyloid-β Peptide Disrupt Membrane Trafficking of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptor Contributing to Early Synapse Dysfunction. J. Biol. Chem. 2011, 286, 27311–27321. [CrossRef] 27. Guntupalli, S.; Widagdo, J.; Anggono, V. Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking. Neural Plast. 2016, 2016, 3204519. [CrossRef] 28. Ammassari-Teule, M. Early-Occurring Dendritic Spines Alterations in Mouse Models of Alzheimer’s Disease Inform on Primary Causes of Neurodegeneration. Front. Synaptic Neurosci. 2020, 12, 566615. [CrossRef] 29. Kanoski, S.E.; Davidson, T.L. Western Diet Consumption and Cognitive Impairment: Links to Hippocampal Dysfunction and Obesity. Physiol. Behav. 2011, 103, 59–68. [CrossRef] 30. Moult, P.R.; Cross, A.; Santos, S.D.; Carvalho, A.-L.; Lindsay, Y.; Connolly, C.N.; Irving, A.J.; Leslie, N.R.; Harvey, J. Leptin Regulates AMPA Receptor Trafficking via PTEN Inhibition. J. Neurosci. 2010, 30, 4088–4101. [CrossRef] 31. Ribeiro, L.F.; Catarino, T.; Santos, S.D.; Benoist, M.; van Leeuwen, J.F.; Esteban, J.A.; Carvalho, A.L. Ghrelin Triggers the Synaptic Incorporation of AMPA Receptors in the Hippocampus. Proc. Natl. Acad. Sci. USA 2014, 111, E149–E158. [CrossRef] 32. Spinelli, M.; Fusco, S.; Mainardi, M.; Scala, F.; Natale, F.; Lapenta, R.; Mattera, A.; Rinaudo, M.; Li Puma, D.D.; Ripoli, C.; et al. Brain Insulin Resistance Impairs Hippocampal Synaptic Plasticity and Memory by Increasing GluA1 Palmitoylation through FoxO3a. Nat. Commun. 2017, 8, 2009. [CrossRef] 33. Ouyang, J.; Carcea, I.; Schiavo, J.K.; Jones, K.T.; Rabinowitsch, A.; Kolaric, R.; Cabeza de Vaca, S.; Froemke, R.C.; Carr, K.D. Food Restriction Induces Synaptic Incorporation of Calcium-Permeable AMPA Receptors in Nucleus Accumbens. Eur. J. Neurosci. 2017, 45, 826–836. [CrossRef] [PubMed] 34. Casas, M.; Fadó, R.; Domínguez, J.L.; Roig, A.; Kaku, M.; Chohnan, S.; Solé, M.; Unzeta, M.; Miñano-Molina, A.J.; Rodríguez- Álvarez, J.; et al. Sensing of Nutrients by CPT1C Controls SAC1 Activity to Regulate AMPA Receptor Trafficking. J. Cell Biol. 2020, 219, e201912045. [CrossRef] [PubMed] 35. Vilarnau, C.; Stracker, D.M.; Funtikov, A.; da Silva, R.; Estruch, R.; Bach-Faig, A. Worldwide Adherence to Mediterranean Diet between 1960 and 2011. Eur. J. Clin. Nutr. 2019, 72, 83–91. [CrossRef] [PubMed] 36. Muñoz-García, M.I.; Martínez-González, M.A.; Razquin, C.; Fernández-Matarrubia, M.; Guillén-Grima, F.; Toledo, E. Exploratory Dietary Patterns and Cognitive Function in the “Seguimiento Universidad de Navarra” (SUN) Prospective Cohort. Eur. J. Clin. Nutr. 2022, 76, 48–55. [CrossRef] [PubMed] 37. Attuquayefio, T.; Stevenson, R.J.; Oaten, M.J.; Francis, H.M. A Four-Day Western-Style Dietary Intervention Causes Reductions in Hippocampal-Dependent Learning and Memory and Interoceptive Sensitivity. PLoS ONE 2017, 12, e0172645. [CrossRef] 38. Stevenson, R.J.; Francis, H.M.; Attuquayefio, T.; Gupta, D.; Yeomans, M.R.; Oaten, M.J.; Davidson, T. Hippocampal-Dependent Appetitive Control Is Impaired by Experimental Exposure to a Western-Style Diet. R. Soc. Open Sci. 2020, 7, 191338. [CrossRef] 39. Ashby-Mitchell, K.; Peeters, A.; Anstey, K.J. Role of Dietary Pattern Analysis in Determining Cognitive Status in Elderly Australian Adults. Nutrients 2015, 7, 1052–1067. [CrossRef] 40. Taylor, Z.B.; Stevenson, R.J.; Ehrenfeld, L.; Francis, H.M. The Impact of Saturated Fat, Added Sugar and Their Combination on Human Hippocampal Integrity and Function: A Systematic Review and Meta-Analysis. Neurosci. Biobehav. Rev. 2021, 130, 91–106. [CrossRef] 41. Hargrave, S.L.; Davidson, T.L. Western Diets Induce Blood-Brain Barrier Leakage and Alter Spatial Strategies in Rats. Behav. Neurosci. 2016, 130, 123–135. [CrossRef] 42. Nakajima, S.; Fukasawa, K.; Gotoh, M.; Murakami-Murofushi, K.; Kunugi, H. Saturated Fatty Acid Is a Principal Cause of Anxiety-like Behavior in Diet-Induced Obese Rats in Relation to Serum Lysophosphatidyl Choline Level. Int. J. Obes. 2019, 44, 727–738. [CrossRef] 43. Dharavath, R.N.; Arora, S.; Bishnoi, M.; Kondepudi, K.K.; Chopra, K. High Fat-Low Protein Diet Induces Metabolic Alterations and Cognitive Dysfunction in Female Rats. Metab. Brain Dis. 2019, 34, 1531–1546. [CrossRef] [PubMed] 44. Tsan, L.; Sun, S.; Hayes, A.M.R.; Bridi, L.; Chirala, L.S.; Noble, E.E.; Fodor, A.A.; Kanoski, S.E. Early Life Western Diet-Induced Memory Impairments and Gut Microbiome Changes in Female Rats Are Long-Lasting despite Healthy Dietary Intervention. Nutr. Neurosci. 2021, 1–17. [CrossRef] 45. Sarfert, K.S.; Knabe, M.L.; Gunawansa, N.S.; Blythe, S.N. Western-Style Diet Induces Object Recognition Deficits and Alters Complexity of Dendritic Arborization in the Hippocampus and Entorhinal Cortex of Male Rats. Nutr. Neurosci. 2019, 22, 344–353. [CrossRef] [PubMed] 46. Leigh, S.J.; Kaakoush, N.O.; Westbrook, R.F.; Morris, M.J. Minocycline-Induced Microbiome Alterations Predict Cafeteria Diet-Induced Spatial Recognition Memory Impairments in Rats. Transl. Psychiatry 2020, 10, 92. [CrossRef] [PubMed] 47. Molteni, R.; Wu, A.; Vaynman, S.; Ying, Z.; Barnard, R.J.; Gómez-Pinilla, F. Exercise Reverses the Harmful Effects of Consumption of a High-Fat Diet on Synaptic and Behavioral Plasticity Associated to the Action of Brain-Derived Neurotrophic Factor. Neuroscience 2004, 123, 429–440. [CrossRef] [PubMed] 48. Lord, M.N.; Heo, J.W.; Schifino, A.G.; Hoffman, J.R.; Donohue, K.N.; Call, J.A.; Noble, E.E. Sexually Dimorphic Effects of a Western Diet on Brain Mitochondrial Bioenergetics and Neurocognitive Function. Nutrients 2021, 13, 4222. [CrossRef] [PubMed] Nutrients 2022, 14, 4137 29 of 36 49. Beilharz, J.E.; Maniam, J.; Morris, M.J. Short Exposure to a Diet Rich in Both Fat and Sugar or Sugar Alone Impairs Place, but Not Object Recognition Memory in Rats. Brain. Behav. Immun. 2014, 37, 134–141. [CrossRef] 50. Beilharz, J.E.; Kaakoush, N.O.; Maniam, J.; Morris, M.J. Cafeteria Diet and Probiotic Therapy: Cross Talk among Memory, Neuroplasticity, Serotonin Receptors and Gut Microbiota in the Rat. Mol. Psychiatry 2018, 23, 351–361. [CrossRef] 51. Alzoubi, K.H.; Khabour, O.F.; Salah, H.A.; Hasan, Z. Vitamin E Prevents High-Fat High-Carbohydrates Diet-Induced Memory Impairment: The Role of Oxidative Stress. Physiol. Behav. 2013, 119, 72–78. [CrossRef] 52. Tran, D.M.D.; Westbrook, R.F. A High-Fat High-Sugar Diet-Induced Impairment in Place-Recognition Memory Is Reversible and Training-Dependent. Appetite 2017, 110, 61–71. [CrossRef] 53. Francis, H.M.; Mirzaei, M.; Pardey, M.C.; Haynes, P.A.; Cornish, J.L. Proteomic Analysis of the Dorsal and Ventral Hippocampus of Rats Maintained on a High Fat and Refined Sugar Diet. Proteomics 2013, 13, 3076–3091. [CrossRef] [PubMed] 54. Jena, P.K.; Sheng, L.; Nguyen, M.; Di Lucente, J.; Hu, Y.; Li, Y.; Maezawa, I.; Jin, L.W.; Wan, Y.J.Y. Dysregulated Bile Acid Receptor-Mediated Signaling and IL-17A Induction Are Implicated in Diet-Associated Hepatic Health and Cognitive Function. Biomark. Res. 2020, 8, 59. [CrossRef] [PubMed] 55. Paulo, S.L.; Miranda-Lourenço, C.; Belo, R.F.; Rodrigues, R.S.; Fonseca-Gomes, J.; Tanqueiro, S.R.; Geraldes, V.; Rocha, I.; Sebastião, A.M.; Xapelli, S.; et al. High Caloric Diet Induces Memory Impairment and Disrupts Synaptic Plasticity in Aged Rats. Curr. Issues Mol. Biol. 2021, 43, 2305–2319. [CrossRef] [PubMed] 56. Syeda, T.; Sánchez-Tapia, M.; Orta, I.; Granados-Portillo, O.; Pérez-Jimenez, L.; Rodríguez-Callejas, J.D.D.; Toribio, S.; Silva-Lucero, M.D.C.; Rivera, A.L.; Tovar, A.R.; et al. Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes. Nutrients 2021, 14, 22. [CrossRef] 57. Mamo, J.C.L.; Lam, V.; Brook, E.; Mooranian, A.; Al-Salami, H.; Fimognari, N.; Nesbit, M.; Takechi, R. Probucol Prevents Blood-Brain Barrier Dysfunction and Cognitive Decline in Mice Maintained on pro-Diabetic Diet. Diabetes Vasc. Dis. Res. 2019, 16, 87–97. [CrossRef] 58. Abd-Allah, H.; Nasr, M.; Ahmed-Farid, O.A.H.; El-Marasy, S.A.; Bakeer, R.M.; Ahmed, R.F. Biological and Pharmacological Characterization of Ascorbic Acid and Nicotinamide Chitosan Nanoparticles against Insulin-Resistance-Induced Cognitive Defects: A Comparative Study. ACS Omega 2021, 6, 3587–3601. [CrossRef] 59. Lama, A.; Pirozzi, C.; Annunziata, C.; Morgese, M.G.; Senzacqua, M.; Severi, I.; Calignano, A.; Trabace, L.; Giordano, A.; Meli, R.; et al. Palmitoylethanolamide Counteracts Brain Fog Improving Depressive-like Behaviour in Obese Mice: Possible Role of Synaptic Plasticity and Neurogenesis. Br. J. Pharmacol. 2021, 178, 845–859. [CrossRef] 60. Kothari, V.; Luo, Y.; Tornabene, T.; O’Neill, A.M.; Greene, M.W.; Geetha, T.; Babu, J.R. High Fat Diet Induces Brain Insulin Resistance and Cognitive Impairment in Mice. Biochim. Biophys. Acta-Mol. Basis Dis. 2017, 1863, 499–508. [CrossRef] 61. Virtuoso, A.; Tveden-nyborg, P.; Schou-pedersen, A.M.V.; Lykkesfeldt, J.; Müller, H.K.; Elfving, B.; Sørensen, D.B. A Long-Term Energy-Rich Diet Increases Prefrontal BDNF in Sprague-Dawley Rats. Nutrients 2021, 14, 126. [CrossRef] 62. Kanoski, S.; Zhang, Y.; Zheng, W.; Davidson, T. The Effects of a High-Energy Diet on Hippocampal-Dependent Negative Occasion Setting and Blood-Brain Barrier Integrity in the Rat. J. Alzheimer’s Dis. 2010, 21, 207–219. [CrossRef] 63. Molteni, R.; Barnard, R.J.; Ying, Z.; Roberts, C.K.; Gómez-Pinilla, F. A High-Fat, Refined Sugar Diet Reduces Hippocampal Brain-Derived Neurotrophic Factor, Neuronal Plasticity, and Learning. Neuroscience 2002, 112, 803–814. [CrossRef] 64. Stranahan, A.M.; Norman, E.D.; Lee, K.; Cutler, R.G.; Telljohann, R.S.; Egan, J.M.; Mattson, M.P. Diet-Induced Insulin Resistance Impairs Hippocampal Synaptic Plasticity and Cognition in Middle-Aged Rats. Hippocampus 2008, 18, 1085–1088. [CrossRef] [PubMed] 65. Garcia-Serrano, A.M.; Mohr, A.A.; Philippe, J.; Skoug, C.; Spégel, P.; Duarte, J.M.N. Cognitive Impairment and Metabolite Profile Alterations in the Hippocampus and Cortex of Male and Female Mice Exposed to a Fat and Sugar-Rich Diet Are Normalized by Diet Reversal. Aging Dis. 2022, 13, 267–283. [CrossRef] [PubMed] 66. Hansen, S.N.; Ipsen, D.H.; Schou-Pedersen, A.M.; Lykkesfeldt, J.; Tveden-Nyborg, P. Long Term Westernized Diet Leads to Region-Specific Changes in Brain Signaling Mechanisms. Neurosci. Lett. 2018, 676, 85–91. [CrossRef] [PubMed] 67. Marwitz, S.E.; Woodie, L.N.; Blythe, S.N. Western-Style Diet Induces Insulin Insensitivity and Hyperactivity in Adolescent Male Rats. Physiol. Behav. 2015, 151, 147–154. [CrossRef] [PubMed] 68. Wang, J.; Wang, Z.; Li, B.; Qiang, Y.; Yuan, T.; Tan, X.; Wang, Z.; Liu, Z.; Liu, X. Lycopene Attenuates Western-Diet-Induced Cognitive Deficits via Improving Glycolipid Metabolism Dysfunction and Inflammatory Responses in Gut-Liver-Brain Axis. Int. J. Obes. 2019, 43, 1735–1746. [CrossRef] [PubMed] 69. Martínez-Orozco, H.; Reyes-Castro, L.A.; Lomas-Soria, C.; Sandoval-Salazar, C.; Ramírez-Emiliano, J.; Díaz-Cintra, S.; Solís-Ortiz, S. High-Fat and Combined High-Fat–High-Fructose Diets Impair Episodic-like Memory and Decrease Glutamate and Glutamine in the Hippocampus of Adult Mice. Nutr. Neurosci. 2021, 1–11. [CrossRef] 70. Kanoski, S.E.; Meisel, R.L.; Mullins, A.J.; Davidson, T.L. Of the Rat. Behav. Brain Res. 2007, 182, 57–66. [CrossRef] 71. Chávez-Gutiérrez, E.; Fuentes-Venado, C.E.; Rodríguez-Páez, L.; Guerra-Araiza, C.; Larqué, C.; Martínez-Herrera, E.; Ocharan- Hernández, M.E.; Lomelí, J.; Loza-Mejía, M.A.; Salazar, J.R.; et al. High Fructose and High Fat Diet Impair Different Types of Memory through Oxidative Stress in a Sex- and Hormone-Dependent Manner. Metabolites 2022, 12, 341. [CrossRef] 72. Takechi, R.; Lam, V.; Brook, E.; Giles, C.; Fimognari, N.; Mooranian, A.; Al-Salami, H.; Coulson, S.H.; Nesbit, M.; Mamo, J.C.L. Blood-Brain Barrier Dysfunction Precedes Cognitive Decline and Neurodegeneration in Diabetic Insulin Resistant Mouse Model: An Implication for Causal Link. Front. Aging Neurosci. 2017, 9, 399. [CrossRef] Nutrients 2022, 14, 4137 30 of 36 73. Zimmerman, B.; Kundu, P.; Liu, Z.; Urbanski, H.F.; Kroenke, C.D.; Kohama, S.G.; Bethea, C.L.; Raber, J. Longitudinal Effects of Immediate and Delayed Estradiol on Cognitive Performance in a Spatial Maze and Hippocampal Volume in Menopausal Macaques Under an Obesogenic Diet. Front. Neurol. 2020, 11, 539. [CrossRef] [PubMed] 74. Thériault, P.; ElAli, A.; Rivest, S. High Fat Diet Exacerbates Alzheimer’s Disease-Related Pathology in APPswe/PS1 Mice. Oncotarget 2016, 7, 67808–67827. [CrossRef] [PubMed] 75. Ivanova, N.; Liu, Q.; Agca, C.; Agca, Y.; Noble, E.G.; Whitehead, S.N.; Cechetto, D.F. White Matter Inflammation and Cognitive Function in a Co-Morbid Metabolic Syndrome and Prodromal Alzheimer’s Disease Rat Model. J. Neuroinflam. 2020, 17, 29. [CrossRef] [PubMed] 76. Jenkins, T.A. Metabolic Syndrome and Vascular-Associated Cognitive Impairment: A Focus on Preclinical Investigations. Curr. Diab. Rep. 2022, 22, 333–340. [CrossRef] [PubMed] 77. Kouvari, M.; D’cunha, N.M.; Travica, N.; Sergi, D.; Zec, M.; Marx, W.; Naumovski, N. Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review. Nutrients 2022, 14, 333. [CrossRef] 78. Sinha, K.; Sun, C.; Kamari, R.; Bettermann, K. Current Status and Future Prospects of Pathophysiology-Based Neuroprotective Drugs for the Treatment of Vascular Dementia. Drug Discov. Today 2020, 25, 793–799. [CrossRef] 79. Appleton, J.P.; Scutt, P.; Sprigg, N.; Bath, P.M. Hypercholesterolaemia and Vascular Dementia. Clin. Sci. 2017, 131, 1561–1578. [CrossRef] 80. Martínez-Lapiscina, E.H.; Clavero, P.; Toledo, E.; Estruch, R.; Salas-Salvadó, J.; San Julián, B.; Sanchez-Tainta, A.; Ros, E.; Valls-Pedret, C.; Martinez-Gonzalez, M.Á. Mediterranean Diet Improves Cognition: The Predimed-Navarra Randomised Trial. J. Neurol. Neurosurg. Psychiatry 2013, 84, 1318–1325. [CrossRef] 81. Karimi, G.; Heidari, Z.; Firouzi, S.; Haghighatdoost, F. A Systematic Review and Meta-Analysis of the Association between Fish Consumption and Risk of Metabolic Syndrome. Nutr. Metab. Cardiovasc. Dis. 2020, 30, 717–729. [CrossRef] 82. Shin, J.Y.; Kim, J.Y.; Kang, H.T.; Han, K.H.; Shim, J.Y. Effect of Fruits and Vegetables on Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int. J. Food Sci. Nutr. 2015, 66, 416–425. [CrossRef] 83. Borroni, B.; Stanic, J.; Verpelli, C.; Mellone, M.; Bonomi, E.; Alberici, A.; Bernasconi, P.; Culotta, L.; Zianni, E.; Archetti, S.; et al. Anti-AMPA GluA3 Antibodies in Frontotemporal Dementia: A New Molecular Target. Sci. Rep. 2017, 7, 6723. [CrossRef] [PubMed] 84. Fortin, D.A.; Srivastava, T.; Dwarakanath, D.; Pierre, P.; Nygaard, S.; Derkach, V.A.; Soderling, T.R. Brain-Derived Neurotrophic Factor Activation of CaM-Kinase Kinase via Transient Receptor Potential Canonical Channels Induces the Translation and Synaptic Incorporation of GluA1-Containing Calcium-Permeable AMPA Receptors. J. Neurosci. 2012, 32, 8127–8137. [CrossRef] [PubMed] 85. Gray, J.A.; Shi, Y.; Usui, H.; During, M.J.; Sakimura, K.; Nicoll, R.A. Distinct Modes of AMPA Receptor Suppression at Developing Synapses by GluN2A and GluN2B: Single-Cell NMDA Receptor Subunit Deletion in Vivo. Neuron 2011, 71, 1085–1101. [CrossRef] [PubMed] 86. Baym, C.L.; Khan, N.A.; Monti, J.M.; Raine, L.B.; Drollette, E.S.; Moore, R.D.; Scudder, M.R.; Kramer, A.F.; Hillman, C.H.; Cohen, N.J. Dietary Lipids Are Differentially Associated with Hippocampal-Dependent Relational Memory in Prepubescent Children. Am. J. Clin. Nutr. 2014, 99, 1026–1033. [CrossRef] [PubMed] 87. Martin, A.A.; Davidson, T.L.; McCrory, M.A. Deficits in Episodic Memory Are Related to Uncontrolled Eating in a Sample of Healthy Adults. Appetite 2018, 124, 33. [CrossRef] 88. Okereke, O.I.; Rosner, B.A.; Kim, D.H.; Kang, J.H.; Cook, N.R.; Manson, J.E.; Buring, J.E.; Willett, W.C.; Grodstein, F. Dietary Fat Types and 4-Year Cognitive Change in Community-Dwelling Older Women. Ann. Neurol. 2012, 72, 124–134. [CrossRef] 89. Golomb, B.A.; Bui, A.K. A Fat to Forget: Trans Fat Consumption and Memory. PLoS ONE 2015, 10, e0128129. [CrossRef] 90. Leigh Gibson, E.; Barr, S.; Jeanes, Y.M. Habitual Fat Intake Predicts Memory Function in Younger Women. Front. Hum. Neurosci. 2013, 7, 838. [CrossRef] 91. Noble, E.E.; Kanoski, S.E. Early Life Exposure to Obesogenic Diets and Learning and Memory Dysfunction. Curr. Opin. Behav. Sci. 2016, 9, 7–14. [CrossRef] 92. Spencer, S.J.; D’Angelo, H.; Soch, A.; Watkins, L.R.; Maier, S.F.; Barrientos, R.M. High-Fat Diet and Aging Interact to Produce Neuroinflammation and Impair Hippocampal- and Amygdalar-Dependent Memory. Neurobiol. Aging 2017, 58, 88–101. [CrossRef] 93. Yang, X.; Zheng, M.; Hao, S.; Shi, H.; Lin, D.; Chen, X.; Becvarovski, A.; Pan, W.; Zhang, P.; Hu, M.; et al. Curdlan Prevents the Cognitive Deficits Induced by a High-Fat Diet in Mice via the Gut-Brain Axis. Front. Neurosci. 2020, 14, 384. [CrossRef] [PubMed] 94. Kim, D.; Cho, J.; Lee, I.; Jin, Y.; Kang, H. Exercise Attenuates High-Fat Diet-Induced Disease Progression in 3xTg-AD Mice. Med. Sci. Sports Exerc. 2017, 49, 676–686. [CrossRef] [PubMed] 95. Wang, J.; Freire, D.; Knable, L.; Zhao, W.; Gong, B.; Mazzola, P.; Ho, L.; Levine, S.; Pasinetti, G.M. Childhood and Adolescent Obesity and Long-Term Cognitive Consequences during Aging. J. Comp. Neurol. 2015, 523, 757–768. [CrossRef] [PubMed] 96. Davis, J.A.; Paul, J.R.; Yates, S.D.; Cutts, E.J.; McMahon, L.L.; Pollock, J.S.; Pollock, D.M.; Bailey, S.M.; Gamble, K.L. Time-Restricted Feeding Rescues High-Fat-Diet-Induced Hippocampal Impairment. iScience 2021, 24, 102532. [CrossRef] [PubMed] 97. Wu, J.; Zhu, Y.; Zhou, L.; Lu, Y.; Feng, T.; Dai, M.; Liu, J.; Xu, W.; Cheng, W.; Sun, F.; et al. Parasite-Derived Excretory-Secretory Products Alleviate Gut Microbiota Dysbiosis and Improve Cognitive Impairment Induced by a High-Fat Diet. Front. Immunol. 2021, 12, 710513. [CrossRef] [PubMed] Nutrients 2022, 14, 4137 31 of 36 98. Hahm, J.R.; Jo, M.H.; Ullah, R.; Kim, M.W.; Kim, M.O. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer’s Like Pathology in Mice Brain. Cells 2020, 9, 249. [CrossRef] [PubMed] 99. Shi, H.; Wang, Q.; Zheng, M.; Hao, S.; Lum, J.S.; Chen, X.; Huang, X.F.; Yu, Y.; Zheng, K. Supplement of Microbiota-Accessible Carbohydrates Prevents Neuroinflammation and Cognitive Decline by Improving the Gut Microbiota-Brain Axis in Diet-Induced Obese Mice. J. Neuroinflam. 2020, 17, 77. [CrossRef] 100. Beilharz, J.E.; Kaakoush, N.O.; Maniam, J.; Morris, M.J. The Effect of Short-Term Exposure to Energy-Matched Diets Enriched in Fat or Sugar on Memory, Gut Microbiota and Markers of Brain Inflammation and Plasticity. Brain. Behav. Immun. 2016, 57, 304–313. [CrossRef] 101. Granholm, A.C.; Bimonte-Nelson, H.A.; Moore, A.B.; Nelson, M.E.; Freeman, L.R.; Sambamurti, K. Effects of a Saturated Fat and High Cholesterol Diet on Memory and Hippocampal Morphology in the Middle-Aged Rat. J. Alzheimer’s Dis. 2008, 14, 133–145. [CrossRef] 102. Fernández-Felipe, J.; Merino, B.; Sanz-Martos, A.B.; Plaza, A.; Contreras, A.; Naranjo, V.; Morales, L.; Chowen, J.A.; Cano, V.; Ruiz-Gayo, M.; et al. Saturated and Unsaturated Fat Diets Impair Hippocampal Glutamatergic Transmission in Adolescent Mice. Psychoneuroendocrinology 2021, 133, 105429. [CrossRef] 103. Khazen, T.; Hatoum, O.A.; Ferreira, G.; Maroun, M. Acute Exposure to a High-Fat Diet in Juvenile Male Rats Disrupts Hippocampal-Dependent Memory and Plasticity through Glucocorticoids. Sci. Rep. 2019, 9, 12270. [CrossRef] [PubMed] 104. Contreras, A.; Del Rio, D.; Martínez, A.; Gil, C.; Morales, L.; Ruiz-Gayo, M.; Del Olmo, N. Inhibition of Hippocampal Long-Term Potentiation by High-Fat Diets: Is It Related to an Effect of Palmitic Acid Involving Glycogen Synthase Kinase-3? Neuroreport 2017, 28, 354–359. [CrossRef] [PubMed] 105. De Paula, G.C.; Brunetta, H.S.; Engel, D.F.; Gaspar, J.M.; Velloso, L.A.; Engblom, D.; de Oliveira, J.; de Bem, A.F. Hippocampal Function Is Impaired by a Short-Term High-Fat Diet in Mice: Increased Blood-Brain Barrier Permeability and Neuroinflammation as Triggering Events. Front. Neurosci. 2021, 15, 734158. [CrossRef] [PubMed] 106. Chiazza, F.; Bondi, H.; Masante, I.; Ugazio, F.; Bortolotto, V.; Canonico, P.L.; Grilli, M. Short High Fat Diet Triggers Reversible and Region Specific Effects in DCX + Hippocampal Immature Neurons of Adolescent Male Mice. Sci. Rep. 2021, 11, 21499. [CrossRef] 107. McLean, F.H.; Campbell, F.M.; Sergi, D.; Grant, C.; Morris, A.C.; Hay, E.A.; MacKenzie, A.; Mayer, C.D.; Langston, R.F.; Williams, L.M. Early and Reversible Changes to the Hippocampal Proteome in Mice on a High-Fat Diet. Nutr. Metab. 2019, 16, 57. [CrossRef] 108. Butler, M.J.; Cole, R.M.; Deems, N.P.; Belury, M.A.; Barrientos, R.M. Fatty Food, Fatty Acids, and Microglial Priming in the Adult and Aged Hippocampus and Amygdala. Brain. Behav. Immun. 2020, 89, 145–158. [CrossRef] 109. Arcego, D.M.; Toniazzo, A.P.; Krolow, R.; Lampert, C.; Berlitz, C.; dos Santos Garcia, E.; do Couto Nicola, F.; Hoppe, J.B.; Gaelzer, M.M.; Klein, C.P.; et al. Impact of High-Fat Diet and Early Stress on Depressive-Like Behavior and Hippocampal Plasticity in Adult Male Rats. Mol. Neurobiol. 2018, 55, 2740–2753. [CrossRef] 110. Mainardi, M.; Spinelli, M.; Scala, F.; Mattera, A.; Fusco, S.; D’Ascenzo, M.; Grassi, C. Loss of Leptin-Induced Modulation of Hippocampal Synaptic Trasmission and Signal Transduction in High-Fat Diet-Fed Mice. Front. Cell. Neurosci. 2017, 11, 225. [CrossRef] 111. Vinuesa, A.; Bentivegna, M.; Calfa, G.; Filipello, F.; Pomilio, C.; Bonaventura, M.M.; Lux-Lantos, V.; Matzkin, M.E.; Gregosa, A.; Presa, J.; et al. Early Exposure to a High-Fat Diet Impacts on Hippocampal Plasticity: Implication of Microglia-Derived Exosome-like Extracellular Vesicles. Mol. Neurobiol. 2019, 56, 5075–5094. [CrossRef] 112. Dingess, P.M.; Darling, R.A.; Kurt Dolence, E.; Culver, B.W.; Brown, T.E. Exposure to a Diet High in Fat Attenuates Dendritic Spine Density in the Medial Prefrontal Cortex. Brain Struct. Funct. 2017, 222, 1077–1085. [CrossRef] 113. Spinelli, M.; Natale, F.; Rinaudo, M.; Leone, L.; Mezzogori, D.; Fusco, S.; Grassi, C. Neural Stem Cell-Derived Exosomes Revert HFD-Dependent Memory Impairment via CREB-BDNF Signalling. Int. J. Mol. Sci. 2020, 21, 8994. [CrossRef] [PubMed] 114. Liang, L.; Chen, J.; Zhan, L.; Lu, X.; Sun, X.; Sui, H.; Zheng, L.; Xiang, H.; Zhang, F. Endoplasmic Reticulum Stress Impairs Insulin Receptor Signaling in the Brains of Obese Rats. PLoS ONE 2015, 10, e0126384. [CrossRef] [PubMed] 115. Li, F.; Liu, B.-B.; Cai, M.; Li, J.-J.; Lou, S.-J. Excessive Endoplasmic Reticulum Stress and Decreased Neuroplasticity-Associated Proteins in Prefrontal Cortex of Obese Rats and the Regulatory Effects of Aerobic Exercise. Brain Res. Bull. 2018, 140, 52–59. [CrossRef] [PubMed] 116. Gao, X.R.; Chen, Z.; Fang, K.; Xu, J.X.; Ge, J.F. Protective Effect of Quercetin against the Metabolic Dysfunction of Glucose and Lipids and Its Associated Learning and Memory Impairments in NAFLD Rats. Lipids Health Dis. 2021, 20, 164. [CrossRef] 117. Wang, Z.; Ge, Q.; Wu, Y.; Zhang, J.; Gu, Q.; Han, J. Impairment of Long-Term Memory by a Short-Term High-Fat Diet via Hippocampal Oxidative Stress and Alterations in Synaptic Plasticity. Neuroscience 2020, 424, 24–33. [CrossRef] [PubMed] 118. Arnold, S.E.; Lucki, I.; Brookshire, B.R.; Carlson, G.C.; Browne, C.A.; Kazi, H.; Bang, S.; Choi, B.R.; Chen, Y.; McMullen, M.F.; et al. High Fat Diet Produces Brain Insulin Resistance, Synaptodendritic Abnormalities and Altered Behavior in Mice. Neurobiol. Dis. 2014, 67, 79–87. [CrossRef] [PubMed] 119. Pathan, A.R.; Gaikwad, A.B.; Viswanad, B.; Ramarao, P. Rosiglitazone Attenuates the Cognitive Deficits Induced by High Fat Diet Feeding in Rats. Eur. J. Pharmacol. 2008, 589, 176–179. [CrossRef] 120. Asadbegi, M.; Yaghmaei, P.; Salehi, I.; Ebrahim-Habibi, A.; Komaki, A. Neuroprotective Effects of Metformin against Aβ-Mediated Inhibition of Long-Term Potentiation in Rats Fed a High-Fat Diet. Brain Res. Bull. 2016, 121, 178–185. [CrossRef] 121. Wu, A.; Ying, Z.; Gomez-Pinilla, F. Oxidative Stress Modulates Sir2α in Rat Hippocampus and Cerebral Cortex. Eur. J. Neurosci. 2006, 23, 2573–2580. [CrossRef] Nutrients 2022, 14, 4137 32 of 36 122. Lee, S.; Goodson, M.L.; Vang, W.; Rutkowsky, J.; Kalanetra, K.; Bhattacharya, M.; Barile, D.; Raybould, H.E. Human Milk Oligosaccharide 2’-Fucosyllactose Supplementation Improves Gut Barrier Function and Signaling in the Vagal Afferent Pathway in Mice. Food Funct. 2021, 12, 8507–8521. [CrossRef] 123. Kim, J.M.; Lee, U.; Kang, J.Y.; Park, S.K.; Kim, J.C.; Heo, H.J. Matcha Improves Metabolic Imbalance-Induced Cognitive Dysfunction. Oxid. Med. Cell. Longev. 2020, 2020, 8882763. [CrossRef] [PubMed] 124. Pintana, H.; Tanajak, P.; Pratchayasakul, W.; Sa-Nguanmoo, P.; Chunchai, T.; Satjaritanun, P.; Leelarphat, L.; Chattipakorn, N.; Chattipakorn, S.C. Energy Restriction Combined with Dipeptidyl Peptidase-4 Inhibitor Exerts Neuroprotection in Obese Male Rats. Br. J. Nutr. 2016, 116, 1700–1708. [CrossRef] [PubMed] 125. Osborne, D.M.; Fitzgerald, D.P.; Anderson, B.M.; Lee, C.C.; Tessier, P.M.; Mcnay, E.C. Intrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity. Biochim. Biophys. Acta 2016, 1860, 1291–1298. [CrossRef] [PubMed] 126. Kawamura, N.; Katsuura, G.; Yamada-Goto, N.; Novianti, E.; Inui, A.; Asakawa, A. Impaired Brain Fractalkine-CX3CR1 Signaling Is Implicated in Cognitive Dysfunction in Diet-Induced Obese Mice. BMJ Open Diabetes Res. Care 2021, 9, e001492. [CrossRef] 127. Mandwie, M.; Karunia, J.; Niaz, A.; Keay, K.A.; Musumeci, G.; Rennie, C.; McGrath, K.; Al-badri, G.; Castorina, A. Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet. Int. J. Mol. Sci. 2021, 22, 3660. [CrossRef] 128. Roy, P.; Martinelli, I.; Moruzzi, M.; Maggi, F.; Amantini, C.; Micioni Di Bonaventura, M.V.; Cifani, C.; Amenta, F.; Tayebati, S.K.; Tomassoni, D. Ion Channels Alterations in the Forebrain of High-Fat Diet Fed Rats. Eur. J. Histochem. 2021, 65, 3305. [CrossRef] 129. Leyh, J.; Winter, K.; Reinicke, M.; Ceglarek, U.; Bechmann, I.; Landmann, J. Long-Term Diet-Induced Obesity Does Not Lead to Learning and Memory Impairment in Adult Mice. PLoS ONE 2021, 16, e0257921. [CrossRef] 130. Wu, M.; Liao, M.; Huang, R.; Chen, C.; Tian, T.; Wang, H.; Li, J.; Li, J.; Sun, Y.; Wu, C.; et al. Hippocampal Overexpression of TREM2 Ameliorates High Fat Diet Induced Cognitive Impairment and Modulates Phenotypic Polarization of the Microglia. Genes Dis. 2020, 9, 401–414. [CrossRef] 131. Xu, N.; Meng, H.; Liu, T.Y.; Feng, Y.L.; Qi, Y.; Zhang, D.H.; Wang, H.L. Sterol O-Acyltransferase 1 Deficiency Improves Defective Insulin Signaling in the Brains of Mice Fed a High-Fat Diet. Biochem. Biophys. Res. Commun. 2018, 499, 105–111. [CrossRef] 132. Pathak, N.M.; Pathak, V.; Lynch, A.M.; Irwin, N.; Gault, V.A.; Flatt, P.R. Stable Oxyntomodulin Analogues Exert Positive Effects on Hippocampal Neurogenesis and Gene Expression as Well as Improving Glucose Homeostasis in High Fat Fed Mice. Mol. Cell. Endocrinol. 2015, 412, 95–103. [CrossRef] 133. Choi, J.; Yin, T.; Shinozaki, K.; Lampe, J.W.; Stevens, J.F.; Becker, L.B.; Kim, J. Comprehensive Analysis of Phospholipids in the Brain, Heart, Kidney, and Liver: Brain Phospholipids Are Least Enriched with Polyunsaturated Fatty Acids. Mol. Cell. Biochem. 2018, 442, 187–201. [CrossRef] 134. Canhada, S.; Castro, K.; Perry, I.S.; Luft, V.C. Omega-3 Fatty Acids’ Supplementation in Alzheimer’s Disease: A Systematic Review. Nutr. Neurosci. 2018, 21, 529–538. [CrossRef] 135. Rangel-Huerta, O.D.; Gil, A. Effect of Omega-3 Fatty Acids on Cognition: An Updated Systematic Review of Randomized Clinical Trials. Nutr. Rev. 2018, 76, 1–20. [CrossRef] 136. Bauer, I.; Hughes, M.; Rowsell, R.; Cockerell, R.; Pipingas, A.; Crewther, S.; Crewther, D. Omega-3 Supplementation Improves Cognition and Modifies Brain Activation in Young Adults. Hum. Psychopharmacol. 2014, 29, 133–144. [CrossRef] 137. Power, R.; Nolan, J.M.; Prado-Cabrero, A.; Roche, W.; Coen, R.; Power, T.; Mulcahy, R. Omega-3 Fatty Acid, Carotenoid and Vitamin E Supplementation Improves Working Memory in Older Adults: A Randomised Clinical Trial. Clin. Nutr. 2022, 41, 405–414. [CrossRef] [PubMed] 138. Külzow, N.; Witte, A.V.; Kerti, L.; Grittner, U.; Schuchardt, J.P.; Hahn, A.; Flöel, A. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults. J. Alzheimer’s Dis. 2016, 51, 713–725. [CrossRef] 139. Tang, W.; Wang, Y.; Xu, F.; Fan, W.; Zhang, Y.; Fan, K.; Wang, W.; Zhang, Y.; Zhang, C. Omega-3 Fatty Acids Ameliorate Cognitive Dysfunction in Schizophrenia Patients with Metabolic Syndrome. Brain. Behav. Immun. 2020, 88, 529–534. [CrossRef] [PubMed] 140. Rigacci, S.; Stefani, M. Nutraceutical Properties of Olive Oil Polyphenols. An Itinerary from Cultured Cells through Animal Models to Humans. Int. J. Mol. Sci. 2016, 17, 843. [CrossRef] [PubMed] 141. Vinciguerra, F.; Graziano, M.; Hagnäs, M.; Frittitta, L.; Tumminia, A. Influence of the Mediterranean and Ketogenic Diets on Cognitive Status and Decline: A Narrative Review. Nutrients 2020, 12, 1019. [CrossRef] [PubMed] 142. Cutuli, D.; de Bartolo, P.; Caporali, P.; Laricchiuta, D.; Foti, F.; Ronci, M.; Rossi, C.; Neri, C.; Spalletta, G.; Caltagirone, C.; et al. N-3 Polyunsaturated Fatty Acids Supplementation Enhances Hippocampal Functionality in Aged Mice. Front. Aging Neurosci. 2014, 6, 220. [CrossRef] [PubMed] 143. Lee, J.; Park, S.; Lee, J.Y.; Yeo, Y.K.; Kim, J.S.; Lim, J. Improved Spatial Learning and Memory by Perilla Diet Is Correlated with Immunoreactivities to Neurofilament and α-Synuclein in Hilus of Dentate Gyrus. Proteome Sci. 2012, 10, 72. [CrossRef] [PubMed] 144. Lee, A.Y.; Choi, J.M.; Lee, J.; Lee, M.H.; Lee, S.; Cho, E.J. Effects of Vegetable Oils with Different Fatty Acid Compositions on Cognition and Memory Ability in Aβ 25-35-Induced Alzheimer’s Disease Mouse Model. J. Med. Food 2016, 19, 912–921. [CrossRef] [PubMed] 145. Thomas, M.H.; Paris, C.; Magnien, M.; Colin, J.; Pelleïeux, S.; Coste, F.; Escanyé, M.C.; Pillot, T.; Olivier, J.L. Dietary Arachidonic Acid Increases Deleterious Effects of Amyloid-β Oligomers on Learning Abilities and Expression of AMPA Receptors: Putative Role of the ACSL4-CPLA2 Balance. Alzheimer’s Res. Ther. 2017, 9, 69. [CrossRef] [PubMed] Nutrients 2022, 14, 4137 33 of 36 146. Lauretti, E.; Nenov, M.; Dincer, O.; Iuliano, L.; Praticò, D. Extra Virgin Olive Oil Improves Synaptic Activity, Short-Term Plasticity, Memory, and Neuropathology in a Tauopathy Model. Aging Cell 2020, 19, e13076. [CrossRef] 147. Loehfelm, A.; Elder, M.K.; Boucsein, A.; Jones, P.P.; Williams, J.M.; Tups, A. Docosahexaenoic Acid Prevents Palmitate-Induced Insulin-Dependent Impairments of Neuronal Health. FASEB J. 2020, 34, 4635–4652. [CrossRef] [PubMed] 148. Seebohm, G.; Wrobel, E.; Pusch, M.; Dicks, M.; Terhag, J.; Matschke, V.; Rothenberg, I.; Ursu, O.N.; Hertel, F.; Pott, L.; et al. Structural Basis of PI(4,5)P2-Dependent Regulation of GluA1 by Phosphatidylinositol-5-Phosphate 4-Kinase, Type II, Alpha (PIP5K2A). Pflugers Arch. 2014, 466, 1885–1897. [CrossRef] [PubMed] 149. Ji, B.; Skup, M. Roles of Palmitoylation in Structural Long-Term Synaptic Plasticity. Mol. Brain 2021, 14, 8. [CrossRef] 150. Mahalakshmi, B.; Maurya, N.; Da Lee, S.; Kumar, V.B. Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegen- eration. Int. J. Mol. Sci. 2020, 21, 5895. [CrossRef] 151. Phillips, M.C.L. Fasting as a Therapy in Neurological Disease. Nutrients 2019, 11, 2501. [CrossRef] 152. Cansev, M.; Wurtman, R.J.; Sakamoto, T.; Ulus, I.H. Oral Administration of Circulating Precursors for Membrane Phosphatides Can Promote the Synthesis of New Brain Synapses. Alzheimer’s Dement. 2008, 4, S153–S168. [CrossRef] 153. Kavraal, S.; Oncu, S.K.; Bitiktas, S.; Artis, A.S.; Dolu, N.; Gunes, T.; Suer, C. Maternal Intake of Omega-3 Essential Fatty Acids Improves Long Term Potentiation in the Dentate Gyrus and Morris Water Maze Performance in Rats. Brain Res. 2012, 1482, 32–39. [CrossRef] [PubMed] 154. Aryal, S.; Hussain, S.; Drevon, C.A.; Nagelhus, E.; Hvalby, Ø.; Jensen, V.; Walaas, S.I.; Davanger, S. Omega-3 Fatty Acids Regulate Plasticity in Distinct Hippocampal Glutamatergic Synapses. Eur. J. Neurosci. 2019, 49, 40–50. [CrossRef] [PubMed] 155. Dyall, S.C.; Michael, G.J.; Whelpton, R.; Scott, A.G.; Michael-Titus, A.T. Dietary Enrichment with Omega-3 Polyunsaturated Fatty Acids Reverses Age-Related Decreases in the GluR2 and NR2B Glutamate Receptor Subunits in Rat Forebrain. Neurobiol. Aging 2007, 28, 424–439. [CrossRef] [PubMed] 156. Ettcheto, M.; Sánchez-Lopez, E.; Cano, A.; Carrasco, M.; Herrera, K.; Manzine, P.R.; Espinosa-Jimenez, T.; Busquets, O.; Verdaguer, E.; Olloquequi, J.; et al. Dexibuprofen Ameliorates Peripheral and Central Risk Factors Associated with Alzheimer’s Disease in Metabolically Stressed APPswe/PS1dE9 Mice. Cell Biosci. 2021, 11, 141. [CrossRef] 157. Ye, X.; Gao, X.; Scott, T.; Tucker, K.L. Habitual Sugar Intake and Cognitive Function among Middle-Aged and Older Puerto Ricans without Diabetes. Br. J. Nutr. 2011, 106, 1423–1432. [CrossRef] 158. Taha, A.Y.; Gao, F.; Ramadan, E.; Cheon, Y.; Rapoport, S.I.; Kim, H.W. Upregulated Expression of Brain Enzymatic Markers of Arachidonic and Docosahexaenoic Acid Metabolism in a Rat Model of the Metabolic Syndrome. BMC Neurosci. 2012, 13, 131. [CrossRef] 159. Kendig, M.D.; Boakes, R.A.; Rooney, K.B.; Corbit, L.H. Chronic Restricted Access to 10% Sucrose Solution in Adolescent and Young Adult Rats Impairs Spatial Memory and Alters Sensitivity to Outcome Devaluation. Physiol. Behav. 2013, 120, 164–172. [CrossRef] 160. Abbott, K.N.; Morris, M.J.; Westbrook, R.F.; Reichelt, A.C. Sex-Specific Effects of Daily Exposure to Sucrose on Spatial Memory Performance in Male and Female Rats, and Implications for Estrous Cycle Stage. Physiol. Behav. 2016, 162, 52–60. [CrossRef] 161. Ross, A.; Barnett, N.; Faulkner, A.; Hannapel, R.; Parent, M.B. Sucrose Ingestion Induces Glutamate AMPA Receptor Phosphoryla- tion in Dorsal Hippocampal Neurons: Increased Sucrose Experience Prevents This Effect. Behav. Brain Res. 2019, 359, 792–798. [CrossRef] 162. Lemos, C.; Rial, D.; Gonçalves, F.Q.; Pires, J.; Silva, H.B.; Matheus, F.C.; da Silva, A.C.; Marques, J.M.; Rodrigues, R.J.; Jarak, I.; et al. High Sucrose Consumption Induces Memory Impairment in Rats Associated with Electrophysiological Modifications but Not with Metabolic Changes in the Hippocampus. Neuroscience 2016, 315, 196–205. [CrossRef] 163. Soares, E.; Prediger, R.D.; Nunes, S.; Castro, A.A.; Viana, S.D.; Lemos, C.; De Souza, C.M.; Agostinho, P.; Cunha, R.A.; Carvalho, E.; et al. Spatial Memory Impairments in a Prediabetic Rat Model. Neuroscience 2013, 250, 565–577. [CrossRef] 164. Li, J.M.; Yu, R.; Zhang, L.P.; Wen, S.Y.; Wang, S.J.; Zhang, X.Y.; Xu, Q.; Kong, L.D. Dietary Fructose-Induced Gut Dysbiosis Promotes Mouse Hippocampal Neuroinflammation: A Benefit of Short-Chain Fatty Acids. Microbiome 2019, 7, 98. [CrossRef] [PubMed] 165. Liu, W.C.; Wu, C.W.; Tain, Y.L.; Fu, M.H.; Hung, C.Y.; Chen, I.C.; Chen, L.W.; Wu, K.L.H. Oral Pioglitazone Ameliorates Fructose- Induced Peripheral Insulin Resistance and Hippocampal Gliosis but Not Restores Inhibited Hippocampal Adult Neurogenesis. Biochim. Biophys. Acta-Mol. Basis Dis. 2018, 1864, 274–285. [CrossRef] [PubMed] 166. Fierros-Campuzano, J.; Ballesteros-Zebadúa, P.; Manjarrez-Marmolejo, J.; Aguilera, P.; Méndez-Diaz, M.; Prospero-García, O.; Franco-Pérez, J. Irreversible Hippocampal Changes Induced by High Fructose Diet in Rats. Nutr. Neurosci. 2020, 25, 1325–1337. [CrossRef] 167. Agrawal, R.; Noble, E.; Vergnes, L.; Ying, Z.; Reue, K.; Gomez-Pinilla, F. Dietary Fructose Aggravates the Pathobiology of Traumatic Brain Injury by Influencing Energy Homeostasis and Plasticity. J. Cereb. Blood Flow Metab. 2015, 36, 941–953. [CrossRef] 168. Djordjevic, A.; Bursać, B.; Veličković, N.; Vasiljević, A.; Matić, G. The Impact of Different Fructose Loads on Insulin Sensitivity, Inflammation, and PSA-NCAM-Mediated Plasticity in the Hippocampus of Fructose-Fed Male Rats. Nutr. Neurosci. 2015, 18, 66–75. [CrossRef] [PubMed] 169. Agrawal, R.; Gomez-Pinilla, F. “Metabolic Syndrome” in the Brain: Deficiency in Omega-3 Fatty Acid Exacerbates Dysfunctions in Insulin Receptor Signalling and Cognition. J. Physiol. 2012, 590, 2485–2499. [CrossRef] Nutrients 2022, 14, 4137 34 of 36 170. Dos Santos, B.; Schmitz, A.E.; de Almeida, G.R.L.; de Souza, L.F.; Szczepanik, J.C.; Nunes, E.A.; Brunetta, H.S.; Mack, J.M.; Prediger, R.D.; Cunha, M.P.; et al. Fructose Intake Impairs Cortical Antioxidant Defenses Allied to Hyperlocomotion in Middle-Aged C57BL/6 Female Mice. Neurochem. Res. 2020, 45, 2868–2883. [CrossRef] [PubMed] 171. Hsu, T.M.; Konanur, V.R.; Taing, L.; Usui, R.; Kayser, B.D.; Goran, M.I.; Kanoski, S.E. Effects of Sucrose and High Fructose Corn Syrup Consumption on Spatial Memory Function and Hippocampal Neuroinflammation in Adolescent Rats. Hippocampus 2015, 25, 227–239. [CrossRef] 172. Nuthikattu, S.; Milenkovic, D.; Norman, J.E.; Rutledge, J.; Villablanca, A. Inhibition of Soluble Epoxide Hydrolase Is Protective against the Multiomic Effects of a High Glycemic Diet on Brain Microvascular Inflammation and Cognitive Dysfunction. Nutrients 2021, 13, 3913. [CrossRef] 173. Orr, M.E.; Salinas, A.; Buffenstein, R.; Oddo, S. Mammalian Target of Rapamycin Hyperactivity Mediates the Detrimental Effects of a High Sucrose Diet on Alzheimer’s Disease Pathology. Neurobiol. Aging 2014, 35, 1233–1242. [CrossRef] 174. Iacovides, S.; Goble, D.; Paterson, B.; Meiring, R.M. Three Consecutive Weeks of Nutritional Ketosis Has No Effect on Cognitive Function, Sleep, and Mood Compared with a High-Carbohydrate, Low-Fat Diet in Healthy Individuals: A Randomized, Crossover, Controlled Trial. Am. J. Clin. Nutr. 2019, 110, 349–357. [CrossRef] [PubMed] 175. Krikorian, R.; Shidler, M.D.; Dangelo, K.; Couch, S.C.; Benoit, S.C.; Clegg, D.J. Dietary Ketosis Enhances Memory in Mild Cognitive Impairment. Neurobiol. Aging 2012, 33, 425.e19–425.e27. [CrossRef] 176. Ródenas-González, F.; Blanco-Gandía, M.C.; Miñarro, J.; Rodríguez-Arias, M. Cognitive Profile of Male Mice Exposed to a Ketogenic Diet. Physiol. Behav. 2022, 254, 113883. [CrossRef] [PubMed] 177. Miles, K.N.; Skelton, M.R. Male Mice Placed on a Ketogenic Diet from Postnatal Day (P) 21 through Adulthood Have Reduced Growth, Are Hypoactive, Show Increased Freezing in a Conditioned Fear Paradigm, and Have Spatial Learning Deficits. Brain Res. 2020, 1734, 146697. [CrossRef] [PubMed] 178. Zhao, Q.; Stafstrom, C.E.; Fu, D.D.; Hu, Y.; Holmes, G.L. Detrimental Effects of the Ketogenic Diet on Cognitive Function in Rats. Pediatr. Res. 2004, 55, 498–506. [CrossRef] [PubMed] 179. Blaise, J.H.; Ruskin, D.N.; Koranda, J.L.; Masino, S.A. Effects of a Ketogenic Diet on Hippocampal Plasticity in Freely Moving Juvenile Rats. Physiol. Rep. 2015, 3, e12411. [CrossRef] [PubMed] 180. Thio, L.L.; Rensing, N.; Maloney, S.; Wozniak, D.F.; Xiong, C.; Yamada, K.A. A Ketogenic Diet Does Not Impair Rat Behavior or Long-Term Potentiation: BRIEF COMMUNICATION. Epilepsia 2010, 51, 1619–1623. [CrossRef] 181. Silva, M.C.; Rocha, J.; Pires, C.S.; Ribeiro, L.C.; Brolese, G.; Leite, M.C.; Almeida, L.M.V.; Tramontina, F.; Ziegler, D.R.; Gonçalves, C.A. Transitory Gliosis in the CA3 Hippocampal Region in Rats Fed on a Ketogenic Diet. Nutr. Neurosci. 2005, 8, 259–264. [CrossRef] 182. Fukushima, A.; Ogura, Y.; Furuta, M.; Kakehashi, C.; Funabashi, T.; Akema, T. Ketogenic Diet Does Not Impair Spatial Ability Controlled by the Hippocampus in Male Rats. Brain Res. 2015, 1622, 36–42. [CrossRef] 183. Huang, J.; Li, Y.Q.; Wu, C.H.; Zhang, Y.L.; Zhao, S.T.; Chen, Y.J.; Deng, Y.H.; Xuan, A.; Sun, X.D. The Effect of Ketogenic Diet on Behaviors and Synaptic Functions of Naive Mice. Brain Behav. 2019, 9, e01246. [CrossRef] [PubMed] 184. Hernandez, A.R.; Hernandez, C.M.; Campos, K.; Truckenbrod, L.; Federico, Q.; Moon, B.; McQuail, J.A.; Maurer, A.P.; Bizon, J.L.; Burke, S.N. A Ketogenic Diet Improves Cognition and Has Biochemical Effects in Prefrontal Cortex That Are Dissociable From Hippocampus. Front. Aging Neurosci. 2018, 10, 391. [CrossRef] [PubMed] 185. Hernandez, A.R.; Hernandez, C.M.; Truckenbrod, L.M.; Campos, K.T.; McQuail, J.A.; Bizon, J.L.; Burke, S.N. Age and Ketogenic Diet Have Dissociable Effects on Synapse-Related Gene Expression Between Hippocampal Subregions. Front. Aging Neurosci. 2019, 11, 239. [CrossRef] 186. Newman, J.C.; Covarrubias, A.J.; Zhao, M.; Yu, X.; Gut, P.; Ng, C.P.; Huang, Y.; Haldar, S.; Verdin, E. Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice. Cell Metab. 2017, 26, 547–557.e8. [CrossRef] 187. Brownlow, M.L.; Benner, L.; D’Agostino, D.; Gordon, M.N.; Morgan, D. Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer’s Pathology. PLoS ONE 2013, 8, e75713. [CrossRef] 188. Xu, Y.; Jiang, C.; Wu, J.; Liu, P.; Deng, X.; Zhang, Y.; Peng, B.; Zhu, Y. Ketogenic Diet Ameliorates Cognitive Impairment and Neuroinflammation in a Mouse Model of Alzheimer’s Disease. CNS Neurosci. Ther. 2021, 28, 580–592. [CrossRef] [PubMed] 189. Page, K.A.; Williamson, A.; Yu, N.; McNay, E.C.; Dzuira, J.; McCrimmon, R.J.; Sherwin, R.S. Medium-Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support in Vitro Synaptic Transmission during Acute Hypoglycemia. Diabetes 2009, 58, 1237–1244. [CrossRef] 190. Jensen, N.J.; Nilsson, M.; Ingerslev, J.S.; Olsen, D.A.; Fenger, M.; Svart, M.; Møller, N.; Zander, M.; Miskowiak, K.W.; Rungby, J. Effects of β-Hydroxybutyrate on Cognition in Patients with Type 2 Diabetes. Eur. J. Endocrinol. 2020, 182, 233–242. [CrossRef] [PubMed] 191. Yomogida, Y.; Matsuo, J.; Ishida, I.; Ota, M.; Nakamura, K.; Ashida, K.; Kunugi, H. An FMRI Investigation into the Effects of Ketogenic Medium-Chain Triglycerides on Cognitive Function in Elderly Adults: A Pilot Study. Nutrients 2021, 13, 2134. [CrossRef] 192. Fortier, M.; Castellano, C.A.; St-Pierre, V.; Myette-Côté, É.; Langlois, F.; Roy, M.; Morin, M.C.; Bocti, C.; Fulop, T.; Godin, J.P.; et al. A Ketogenic Drink Improves Cognition in Mild Cognitive Impairment: Results of a 6-Month RCT. Alzheimer’s Dement. 2021, 17, 543–552. [CrossRef] Nutrients 2022, 14, 4137 35 of 36 193. Ota, M.; Matsuo, J.; Ishida, I.; Takano, H.; Yokoi, Y.; Hori, H.; Yoshida, S.; Ashida, K.; Nakamura, K.; Takahashi, T.; et al. Effects of a Medium-Chain Triglyceride-Based Ketogenic Formula on Cognitive Function in Patients with Mild-to-Moderate Alzheimer’s Disease. Neurosci. Lett. 2019, 690, 232–236. [CrossRef] 194. Reger, M.A.; Henderson, S.T.; Hale, C.; Cholerton, B.; Baker, L.D.; Watson, G.S.; Hyde, K.; Chapman, D.; Craft, S. Effects of β-Hydroxybutyrate on Cognition in Memory-Impaired Adults. Neurobiol. Aging 2004, 25, 311–314. [CrossRef] 195. Hu, E.; Du, H.; Zhu, X.; Wang, L.; Shang, S.; Wu, X.; Lu, H.; Lu, X. Beta-Hydroxybutyrate Promotes the Expression of BDNF in Hippocampal Neurons under Adequate Glucose Supply. Neuroscience 2018, 386, 315–325. [CrossRef] 196. Wang, D.; Mitchell, E.S. Cognition and Synaptic-Plasticity Related Changes in Aged Rats Supplemented with 8- and 10-Carbon Medium Chain Triglycerides. PLoS ONE 2016, 11, e0160159. [CrossRef] 197. Shippy, D.C.; Wilhelm, C.; Viharkumar, P.A.; Raife, T.J.; Ulland, T.K. β-Hydroxybutyrate Inhibits Inflammasome Activation to Attenuate Alzheimer’s Disease Pathology. J. Neuroinflamm. 2020, 17, 280. [CrossRef] 198. Yin, J.X.; Maalouf, M.; Han, P.; Zhao, M.; Gao, M.; Dharshaun, T.; Ryan, C.; Whitelegge, J.; Wu, J.; Eisenberg, D.; et al. Ketones Block Amyloid Entry and Improve Cognition in an Alzheimer’s Model. Neurobiol. Aging 2016, 39, 25–37. [CrossRef] [PubMed] 199. Kashiwaya, Y.; Pawlosky, R.; Markis, W.; King, M.T.; Bergman, C.; Srivastava, S.; Murray, A.; Clarke, K.; Veech, R.L. A Ketone Ester Diet Increases Brain Malonyl-CoA and Uncoupling Proteins 4 and 5 While Decreasing Food Intake in the Normal Wistar Rat. J. Biol. Chem. 2010, 285, 25950–25956. [CrossRef] [PubMed] 200. Zhang, J.; Cao, Q.; Li, S.; Lu, X.; Zhao, Y.; Guan, J.S.; Chen, J.C.; Wu, Q.; Chen, G.Q. 3-Hydroxybutyrate Methyl Ester as a Potential Drug against Alzheimer’s Disease via Mitochondria Protection Mechanism. Biomaterials 2013, 34, 7552–7562. [CrossRef] [PubMed] 201. Bostock, E.C.S.; Kirkby, K.C.; Taylor, B.V.; Hawrelak, J.A. Consumer Reports of “Keto Flu” Associated With the Ketogenic Diet. Front. Nutr. 2020, 7, 20. [CrossRef] 202. Hori, A.; Tandon, P.; Holmes, G.L.; Stafstrom, C.E. Ketogenic Diet: Effects on Expression of Kindled Seizures and Behavior in Adult Rats. Epilepsia 1997, 38, 750–758. [CrossRef] 203. Thio, L.L.; Wong, M.; Yamada, K.A. Ketone Bodies Do Not Directly Alter Excitatory or Inhibitory Hippocampal Synaptic Transmission. Neurology 2000, 54, 325–331. [CrossRef] [PubMed] 204. Youssef, F.F. Ketone Bodies Attenuate Excitotoxic Cell Injury in the Rat Hippocampal Slice under Conditions of Reduced Glucose Availability. Neurol. Res. 2015, 37, 211–216. [CrossRef] [PubMed] 205. McDaniel, S.S.; Rensing, N.R.; Thio, L.L.; Yamada, K.A.; Wong, M. The Ketogenic Diet Inhibits the Mammalian Target of Rapamycin (MTOR) Pathway. Epilepsia 2011, 52, e7–e11. [CrossRef] [PubMed] 206. Chang, P.; Augustin, K.; Boddum, K.; Williams, S.; Sun, M.; Terschak, J.A.; Hardege, J.D.; Chen, P.E.; Walker, M.C.; Williams, R.S.B. Seizure Control by Decanoic Acid through Direct AMPA Receptor Inhibition. Brain 2016, 139, 431–443. [CrossRef] [PubMed] 207. Augustin, K.; Khabbush, A.; Williams, S.; Eaton, S.; Orford, M.; Cross, J.H.; Heales, S.J.R.; Walker, M.C.; Williams, R.S.B. Mechanisms of Action for the Medium-Chain Triglyceride Ketogenic Diet in Neurological and Metabolic Disorders. Lancet Neurol. 2018, 17, 84–93. [CrossRef] 208. Kolb, H.; Kempf, K.; Röhling, M.; Lenzen-Schulte, M.; Schloot, N.C.; Martin, S. Ketone Bodies: From Enemy to Friend and Guardian Angel. BMC Med. 2021, 19, 313. [CrossRef] 209. Craft, S.; Newcomer, J.; Kanne, S.; Dagogo-Jack, S.; Cryer, P.; Sheline, Y.; Luby, J.; Dagogo-Jack, A.; Alderson, A. Memory Improvement Following Induced Hyperinsulinemia in Alzheimer’s Disease. Neurobiol. Aging 1996, 17, 123–130. [CrossRef] 210. Farris, W.; Mansourian, S.; Chang, Y.; Lindsley, L.; Eckman, E.A.; Frosch, M.P.; Eckman, C.B.; Tanzi, R.E.; Selkoe, D.J.; Guénette, S. Insulin-Degrading Enzyme Regulates the Levels of Insulin, Amyloid β-Protein, and the β-Amyloid Precursor Protein Intracellular Domain in Vivo. Proc. Natl. Acad. Sci. USA 2003, 100, 4162–4167. [CrossRef] 211. Devi, L.; Alldred, M.J.; Ginsberg, S.D.; Ohno, M. Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β- Amyloidosis in a Mouse Model of Alzheimer’s Disease. PLoS ONE 2012, 7, e32792. [CrossRef] 212. Kashiwaya, Y.; Takeshima, T.; Mori, N.; Nakashima, K.; Clarke, K.; Veech, R.L. D-Beta-Hydroxybutyrate Protects Neurons in Models of Alzheimer’s and Parkinson’s Disease. Proc. Natl. Acad. Sci. USA 2000, 97, 5440–5444. [CrossRef] [PubMed] 213. Koppel, S.J.; Pei, D.; Wilkins, H.M.; Weidling, I.W.; Wang, X.; Menta, B.W.; Perez-Ortiz, J.; Kalani, A.; Manley, S.; Novikova, L.; et al. A Ketogenic Diet Differentially Affects Neuron And Astrocyte Transcription. J. Neurochem. 2021, 157, 1930. [CrossRef] [PubMed] 214. Mujica-Parodi, L.R.; Amgalan, A.; Sultan, S.F.; Antal, B.; Sun, X.; Skiena, S.; Lithen, A.; Adra, N.; Ratai, E.M.; Weistuch, C.; et al. Diet Modulates Brain Network Stability, a Biomarker for Brain Aging, in Young Adults. Proc. Natl. Acad. Sci. USA 2020, 117, 6170–6177. [CrossRef] [PubMed] 215. De la O, V.; Zazpe, I.; Martínez, J.A.; Santiago, S.; Carlos, S.; Zulet, M.Á.; Ruiz-Canela, M. Scoping Review of Paleolithic Dietary Patterns: A Definition Proposal. Nutr. Res. Rev. 2020, 34, 78–106. [CrossRef] 216. Du, K.; Markus, E.; Fecych, M.; Rhodes, J.S.; Beverly, J.L. Satiety and Memory Enhancing Effects of a High-Protein Meal Depend on the Source of Protein. Nutr. Neurosci. 2018, 21, 257–267. [CrossRef] [PubMed] 217. Méndez-López, M.; Méndez, M.; Arias, J.; Arias, J.L. Effects of a High Protein Diet on Cognition and Brain Metabolism in Cirrhotic Rats. Physiol. Behav. 2015, 149, 220–228. [CrossRef] 218. Su, Z.W.; Liao, J.Y.; Zhang, H.; Zhang, T.; Wu, F.; Tian, X.H.; Zhang, F.T.; Sun, W.W.; Cui, Q.L. Postnatal High-Protein Diet Improves Learning and Memory in Premature Rats via Activation of MTOR Signaling. Brain Res. 2015, 1611, 1–7. [CrossRef] Nutrients 2022, 14, 4137 36 of 36 219. Boraxbekk, C.J.; Stomby, A.; Ryberg, M.; Lindahl, B.; Larsson, C.; Nyberg, L.; Olsson, T. Diet-Induced Weight Loss Alters Functional Brain Responses during an Episodic Memory Task. Obes. Facts 2015, 8, 261–272. [CrossRef] 220. Stomby, A.; Otten, J.; Ryberg, M.; Nyberg, L.; Olsson, T.; Boraxbekk, C.J. A Paleolithic Diet with and without Combined Aerobic and Resistance Exercise Increases Functional Brain Responses and Hippocampal Volume in Subjects with Type 2 Diabetes. Front. Aging Neurosci. 2017, 9, 391. [CrossRef] 221. Gyorkos, A.; Baker, M.H.; Miutz, L.N.; Lown, D.A.; Jones, M.A.; Houghton-Rahrig, L.D. Carbohydrate-Restricted Diet and Exercise Increase Brain-Derived Neurotrophic Factor and Cognitive Function: A Randomized Crossover Trial. Cureus 2019, 11, e5604. [CrossRef] [PubMed]